Section 7 PE - Results from the 2025 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

260522

Table 7.1A – Severity of Symptoms of Generalized Anxiety Disorder (GAD) in Past 2 Weeks: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	No or Minimal (2024)	No or Minimal (2025)	Mild (2024)	Mild (2025)	Moderate (2024)	Moderate (2025)	Moderate or Severe (2024)	Moderate or Severe (2025)	Severe (2024)	Severe (2025)
TOTAL	15,072	14,856	6,003	6,016	2,740	2,706	4,876	4,582	2,136	1,876
AGE GROUP
12‑13	5,166	5,039	1,693	1,604	674	717	1,236	1,206	563	490
14‑15	4,997	4,982	2,090	2,138	993	919	1,778	1,595	785	676
16‑17	4,909	4,834	2,219	2,275	1,073	1,071	1,863	1,781	789	710
SEX
Male	9,296	8,923	2,559	2,589	898	983	1,420	1,493	522	509
Female	5,776	5,933	3,444	3,427	1,842	1,723	3,456	3,090	1,614^a	1,367
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10,924	10,842	4,488	4,427	1,999	2,002	3,637	3,362	1,639^a	1,361
AIAN	138	185	37	48	17	21	34	38	17	17
Asian	968	936	312	351	150	169	234	244	84	75
Black or African American	2,213	2,147	790	715	357	340	567	550	210	210
NHPI	*	*	*	*	*	*	*	*	*	*
White	7,025	6,789	3,073	3,008	1,343	1,282	2,533	2,220	1,190^a	938
Two or More Races	526^b	748	253	280	127	186	263	305	137	119
Hispanic or Latino	4,148	4,014	1,515	1,590	741	705	1,239	1,220	498	515
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: GAD symptom severity is based on the GAD‑7 scale. GAD‑7 scores indicate the following: 0 to 4 = no or minimal symptoms of GAD, 5 to 9 = mild symptoms, 10 to 14 = moderate symptoms, and 15 to 21 = severe symptoms. The Moderate or Severe category includes respondents with a GAD‑7 score of 10 or greater. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.1B – Severity of Symptoms of Generalized Anxiety Disorder (GAD) in Past 2 Weeks: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	No or Minimal (2024)	No or Minimal (2025)	Mild (2024)	Mild (2025)	Moderate (2024)	Moderate (2025)	Moderate or Severe (2024)	Moderate or Severe (2025)	Severe (2024)	Severe (2025)
TOTAL	58.1	58.4	23.1	23.6	10.6	10.6	18.8	18.0	8.2	7.4
AGE GROUP
12‑13	63.8	64.2	20.9	20.4	8.3	9.1	15.3	15.4	7.0	6.2
14‑15	56.4	57.2	23.6	24.5	11.2	10.5	20.1	18.3	8.8	7.8
16‑17	54.6	54.4	24.7	25.6	11.9	12.0	20.7	20.0	8.8	8.0
SEX
Male	70.0	68.6	19.3	19.9	6.8	7.6	10.7	11.5	3.9	3.9
Female	45.6	47.7	27.2	27.5	14.5	13.8	27.3^a	24.8	12.7^a	11.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	57.3	58.2	23.6	23.8	10.5	10.7	19.1	18.0	8.6^a	7.3
AIAN	66.1	68.4	17.8	17.6	8.0	7.7	16.1	14.0	8.1	6.3
Asian	64.0	61.2	20.6	22.9	9.9	11.1	15.5	15.9	5.6	4.9
Black or African American	62.0	62.9	22.1	20.9	10.0	10.0	15.9	16.1	5.9	6.2
NHPI	*	*	*	*	*	*	*	*	*	*
White	55.6	56.5	24.3	25.0	10.6	10.7	20.1	18.5	9.4^a	7.8
Two or More Races	50.5	56.1	24.3	21.0	12.1	13.9	25.3	22.9	13.1	8.9
Hispanic or Latino	60.1	58.8	21.9	23.3	10.7	10.3	18.0	17.9	7.2	7.6
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: GAD symptom severity is based on the GAD‑7 scale. GAD‑7 scores indicate the following: 0 to 4 = no or minimal symptoms of GAD, 5 to 9 = mild symptoms, 10 to 14 = moderate symptoms, and 15 to 21 = severe symptoms. The Moderate or Severe category includes respondents with a GAD‑7 score of 10 or greater. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.2A – Severity of Symptoms of Generalized Anxiety Disorder (GAD) in Past 2 Weeks: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	No or Minimal (2024)	No or Minimal (2025)	Mild (2024)	Mild (2025)	Moderate (2024)	Moderate (2025)	Moderate or Severe (2024)	Moderate or Severe (2025)	Severe (2024)	Severe (2025)
TOTAL	15,072	14,856	6,003	6,016	2,740	2,706	4,876	4,582	2,136	1,876
GEOGRAPHIC DIVISION
Northeast	2,328	2,375	970	979	449	369	782	644	332	274
New England	577	669	270	226	99	93	196	125	96^a	32
Middle Atlantic	1,751	1,706	699	753	350	276	586	518	236	242
Midwest	3,159	3,102	1,237	1,264	550	557	1,014	940	463	382
East North Central	2,165	2,051	822	891	362	361	664	624	302	264
West North Central	994	1,051	415	373	188	197	350	315	162	119
South	6,113	5,953	2,304	2,193	1,039	1,192	1,907	1,994	868	802
South Atlantic	3,030	2,803	1,196	1,151	501^a	701	904	1,093	403	392
East South Central	880	893	342	323	166	145	329	304	163	159
West South Central	2,203	2,257	766	720	373	346	675	597	302	251
West	3,472	3,426	1,492	1,580	701	587	1,174	1,005	473	418
Mountain	1,095	1,163	555	527	229	204	410	361	181	157
Pacific	2,377	2,263	937	1,052	472	383	764	644	292	262
COUNTY TYPE
Large Metro	8,902	8,472	3,400	3,482	1,545	1,472	2,756	2,550	1,211	1,077
Small Metro	4,518	4,735	1,992	2,013	923	944	1,592	1,458	669^a	514
Nonmetro	1,652	1,648	611	521	272	290	529	575	257	285
Urbanized	636	600	215	160	110	104	188	221	77	116
Less Urbanized	616	689	220	226	102	126	195	249	93	122
Completely Rural	400	359	176	134	60	59	146	106	86	46
POVERTY LEVEL
Less Than 100%	3,411	3,409	1,122	1,124	542	655	985	1,119	442	464
100‑199%	3,121	3,296	1,264	1,386	524	615	935	1,034	411	420
200% or More	8,540	8,151	3,617	3,506	1,674	1,437	2,956^b	2,430	1,283^b	993
HEALTH INSURANCE¹
Private	8,338	7,979	3,440	3,504	1,647	1,437	2,865^b	2,387	1,217^a	950
Medicaid/CHIP	6,162	6,222	2,302	2,295	1,067	1,139	1,985	1,974	918	835
Other²	793	797	340	346	166	163	249	308	84	145
No Coverage	755	691	293	235	80	120	160	199	80	80
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: GAD symptom severity is based on the GAD‑7 scale. GAD‑7 scores indicate the following: 0 to 4 = no or minimal symptoms of GAD, 5 to 9 = mild symptoms, 10 to 14 = moderate symptoms, and 15 to 21 = severe symptoms. The Moderate or Severe category includes respondents with a GAD‑7 score of 10 or greater. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.2B – Severity of Symptoms of Generalized Anxiety Disorder (GAD) in Past 2 Weeks: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	No or Minimal (2024)	No or Minimal (2025)	Mild (2024)	Mild (2025)	Moderate (2024)	Moderate (2025)	Moderate or Severe (2024)	Moderate or Severe (2025)	Severe (2024)	Severe (2025)
TOTAL	58.1	58.4	23.1	23.6	10.6	10.6	18.8	18.0	8.2	7.4
GEOGRAPHIC DIVISION
Northeast	57.1	59.4	23.8	24.5	11.0	9.2	19.2	16.1	8.1	6.9
New England	55.3^a	65.6	25.9	22.1	9.5	9.1	18.8	12.3	9.2^a	3.1
Middle Atlantic	57.7	57.3	23.0	25.3	11.5	9.3	19.3	17.4	7.8	8.1
Midwest	58.4	58.5	22.9	23.8	10.2	10.5	18.7	17.7	8.6	7.2
East North Central	59.3	57.5	22.5	25.0	9.9	10.1	18.2	17.5	8.3	7.4
West North Central	56.5	60.4	23.6	21.5	10.7	11.3	19.9	18.1	9.2	6.8
South	59.2	58.7	22.3	21.6	10.1	11.8	18.5	19.7	8.4	7.9
South Atlantic	59.1	55.5	23.3	22.8	9.8^b	13.9	17.6^a	21.7	7.9	7.8
East South Central	56.7	58.7	22.1	21.2	10.7	9.6	21.2	20.0	10.5	10.5
West South Central	60.5	63.2	21.0	20.1	10.2	9.7	18.5	16.7	8.3	7.0
West	56.6	57.0	24.3	26.3	11.4	9.8	19.1	16.7	7.7	7.0
Mountain	53.1	56.7	27.0	25.7	11.1	10.0	19.9	17.6	8.8	7.6
Pacific	58.3	57.1	23.0	26.6	11.6	9.7	18.7	16.3	7.2	6.6
COUNTY TYPE
Large Metro	59.1	58.4	22.6	24.0	10.3	10.2	18.3	17.6	8.0	7.4
Small Metro	55.8	57.7	24.6	24.5	11.4	11.5	19.6	17.8	8.3^b	6.3
Nonmetro	59.2	60.1	21.9	19.0	9.7	10.6	18.9	20.9	9.2	10.4
Urbanized	61.2	61.2	20.7	16.3	10.6	10.6	18.1	22.5	7.5	11.9
Less Urbanized	59.7	59.2	21.3	19.4	9.9	10.9	18.9	21.4	9.0	10.5
Completely Rural	55.4	60.0	24.4	22.4	8.3	9.9	20.2	17.6	11.9	7.7
POVERTY LEVEL
Less Than 100%	61.8	60.3	20.3	19.9	9.8	11.6	17.8	19.8	8.0	8.2
100‑199%	58.7	57.7	23.8	24.2	9.8	10.8	17.6	18.1	7.7	7.3
200% or More	56.5	57.9	23.9	24.9	11.1	10.2	19.6^a	17.2	8.5^a	7.0
HEALTH INSURANCE¹
Private	56.9	57.5	23.5	25.3	11.3	10.4	19.6^a	17.2	8.3^a	6.9
Medicaid/CHIP	59.0	59.3	22.0	21.9	10.2	10.9	19.0	18.8	8.8	8.0
Other²	57.3	54.9	24.6	23.8	12.0	11.3	18.0	21.2	6.0	10.0
No Coverage	62.5	61.4	24.2	20.9	6.7	10.6	13.3	17.7	6.6	7.1
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: GAD symptom severity is based on the GAD‑7 scale. GAD‑7 scores indicate the following: 0 to 4 = no or minimal symptoms of GAD, 5 to 9 = mild symptoms, 10 to 14 = moderate symptoms, and 15 to 21 = severe symptoms. The Moderate or Severe category includes respondents with a GAD‑7 score of 10 or greater. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.3A – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Had MDE^1,2 (2024)	Had MDE^1,2 (2025)	Had MDE with Severe Impairment^1,3,4 (2024)	Had MDE with Severe Impairment^1,3,4 (2025)
TOTAL	3,840	3,706	2,834	2,717
AGE GROUP
12‑13	767	735	567	503
14‑15	1,366	1,393	1,000	1,029
16‑17	1,706	1,578	1,267	1,186
SEX
Male	1,082	1,092	735	788
Female	2,758	2,614	2,099	1,929
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,824	2,707	2,055	2,032
AIAN	17	26	12	17
Asian	172	143	135	82
Black or African American	364	377	260	278
NHPI	*	*	*	*
White	2,048	1,917	1,483	1,476
Two or More Races	222	234	163	170
Hispanic or Latino	1,016	999	779	685
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.3B – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Had MDE^1,2 (2024)	Had MDE^1,2 (2025)	Had MDE with Severe Impairment^1,3,4 (2024)	Had MDE with Severe Impairment^1,3,4 (2025)
TOTAL	15.4	15.1	11.3	11.0
AGE GROUP
12‑13	10.1	9.8	7.4	6.7
14‑15	16.0	16.4	11.7	12.1
16‑17	19.3	18.3	14.3	13.8
SEX
Male	8.4	8.7	5.7	6.3
Female	22.6	21.7	17.2	16.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.4	15.0	11.2	11.3
AIAN	8.6	9.9	6.1	6.7
Asian	11.9	9.6	9.4	5.6
Black or African American	10.5	11.4	7.5	8.4
NHPI	*	*	*	*
White	16.8	16.4	12.2	12.7
Two or More Races	22.2	18.3	16.4	13.3
Hispanic or Latino	15.4	15.2	11.8	10.4
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.4A – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Had MDE^1,2 (2024)	Had MDE^1,2 (2025)	Had MDE with Severe Impairment^1,3,4 (2024)	Had MDE with Severe Impairment^1,3,4 (2025)
TOTAL	3,840	3,706	2,834	2,717
GEOGRAPHIC DIVISION
Northeast	563	594	449	458
New England	136	110	107	82
Middle Atlantic	427	485	343	377
Midwest	818	760	579	562
East North Central	516	520	365	384
West North Central	303	240	214	178
South	1,482	1,463	1,108	1,056
South Atlantic	653	729	493	504
East South Central	274	268	232	181
West South Central	555	467	383	371
West	976	888	698	641
Mountain	350	317	246	234
Pacific	625	571	453	407
COUNTY TYPE
Large Metro	2,008	2,058	1,513	1,499
Small Metro	1,396	1,224	1,022	908
Nonmetro	436	424	299	311
Urbanized	153	140	109	102
Less Urbanized	142	180	100	134
Completely Rural	141	104	89	75
POVERTY LEVEL
Less Than 100%	765	815	567	640
100‑199%	768	800	607	570
200% or More	2,307	2,090	1,660	1,507
HEALTH INSURANCE⁵
Private	2,218	2,034	1,633	1,446
Medicaid/CHIP	1,581	1,524	1,206	1,149
Other⁶	163^b	286	111^b	218
No Coverage	149	143	96	114
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. ⁵ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁶ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.4B – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Had MDE^1,2 (2024)	Had MDE^1,2 (2025)	Had MDE with Severe Impairment^1,3,4 (2024)	Had MDE with Severe Impairment^1,3,4 (2025)
TOTAL	15.4	15.1	11.3	11.0
GEOGRAPHIC DIVISION
Northeast	14.4	15.2	11.5	11.7
New England	13.5	11.1	10.6	8.3
Middle Atlantic	14.7	16.6	11.8	12.9
Midwest	15.8	14.9	11.2	11.0
East North Central	14.8	15.2	10.4	11.2
West North Central	17.8	14.2	12.7	10.5
South	14.8	14.9	11.1	10.8
South Atlantic	13.2	15.0	9.9	10.4
East South Central	18.0	18.4	15.3	12.4
West South Central	15.7	13.4	10.8	10.7
West	16.6	15.3	11.9	11.1
Mountain	17.8	16.0	12.5	11.8
Pacific	16.0	15.0	11.5	10.7
COUNTY TYPE
Large Metro	13.9	14.7	10.5	10.7
Small Metro	17.8	15.5	13.0	11.5
Nonmetro	16.1	15.8	11.0	11.6
Urbanized	15.0	14.5	10.8	10.6
Less Urbanized	14.2	15.8	10.0	11.7
Completely Rural	20.2	18.0	12.8	13.0
POVERTY LEVEL
Less Than 100%	14.4	15.1	10.7	11.8
100‑199%	15.0	14.5	11.9	10.4
200% or More	15.8	15.3	11.4	11.0
HEALTH INSURANCE⁵
Private	15.7	15.1	11.6	10.7
Medicaid/CHIP	15.7	15.1	12.0	11.4
Other⁶	12.1^b	21.0	8.3^b	16.0
No Coverage	12.9	13.2	8.3	10.5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. ⁵ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁶ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.5A – Types and Locations of Mental Health Treatment and Other Services in Past Year: Among People Aged 12 to 17; by Age Group, Numbers in Thousands, 2024 and 2025
Type/Location of Treatment or Other Services	Aged 12‑17 (2024)	Aged 12‑17 (2025)	Aged 12‑13 (2024)	Aged 12‑13 (2025)	Aged 14‑15 (2024)	Aged 14‑15 (2025)	Aged 16‑17 (2024)	Aged 16‑17 (2025)
MENTAL HEALTH TREATMENT OR OTHER SERVICES¹	‑‑	7,626	‑‑	2,217	‑‑	2,759	‑‑	2,651
MENTAL HEALTH TREATMENT	‑‑	7,029	‑‑	2,066	‑‑	2,525	‑‑	2,437
Inpatient	‑‑	639	‑‑	106	‑‑	257	‑‑	276
Hospital	‑‑	497	‑‑	62	‑‑	218	‑‑	217
Residential Mental Health Treatment Center	‑‑	361	‑‑	61	‑‑	165	‑‑	135
Residential Drug or Alcohol Rehab or Treatment Center	‑‑	137	‑‑	20	‑‑	54	‑‑	63
Some Other Place as an Inpatient	‑‑	155	‑‑	38	‑‑	45	‑‑	72
Outpatient	‑‑	5,160	‑‑	1,485	‑‑	1,842	‑‑	1,832
Mental Health Treatment Center	‑‑	799	‑‑	129	‑‑	375	‑‑	295
Drug or Alcohol Rehab or Treatment Center	‑‑	142	‑‑	28	‑‑	55	‑‑	59
Office of a Therapist, Psychologist, Psychiatrist, or Mental Health Professional	‑‑	3,554	‑‑	874	‑‑	1,294	‑‑	1,385
General Medical Clinic or Doctor’s Office	‑‑	1,353	‑‑	290	‑‑	538	‑‑	525
Hospital	‑‑	412	‑‑	84	‑‑	163	‑‑	165
School’s Health or Counseling Center	‑‑	2,907	‑‑	945	‑‑	1,053	‑‑	908
Some Other Place as an Outpatient	‑‑	358	‑‑	84	‑‑	140	‑‑	134
Outpatient, Other Than General Medical Clinic or Doctor’s Office	‑‑	4,987	‑‑	1,450	‑‑	1,779	‑‑	1,759
Prescription Medication	3,343	3,389	883	857	1,167	1,202	1,293	1,329
Telehealth Treatment²	3,389	3,322	941	782	1,164	1,253	1,283	1,286
Prison, Jail, or Juvenile Detention Center	312	280	97	104	121	80	93	96
OTHER SERVICES
Support Services
Support Group	1,745	1,883	691^a	536	522^b	758	533	590
Peer Support Specialist or Recovery Coach	793	679	260^a	159	255	313	278	207
Emergency Room/Department	684	576	208^b	95	208	239	268	243
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes treatment for mental health, emotions, or behavior through support group services, peer support specialist or recovery coach services, or treatment received in an emergency room/department. ² Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.5B – Types and Locations of Mental Health Treatment and Other Services in Past Year: Among People Aged 12 to 17; by Age Group, Percentages, 2024 and 2025
Type/Location of Treatment or Other Services	Aged 12‑17 (2024)	Aged 12‑17 (2025)	Aged 12‑13 (2024)	Aged 12‑13 (2025)	Aged 14‑15 (2024)	Aged 14‑15 (2025)	Aged 16‑17 (2024)	Aged 16‑17 (2025)
MENTAL HEALTH TREATMENT OR OTHER SERVICES¹	‑‑	30.0	‑‑	28.2	‑‑	31.7	‑‑	29.8
MENTAL HEALTH TREATMENT	‑‑	27.6	‑‑	26.3	‑‑	29.0	‑‑	27.4
Inpatient	‑‑	2.5	‑‑	1.3	‑‑	3.0	‑‑	3.1
Hospital	‑‑	2.0	‑‑	0.8	‑‑	2.5	‑‑	2.4
Residential Mental Health Treatment Center	‑‑	1.4	‑‑	0.8	‑‑	1.9	‑‑	1.5
Residential Drug or Alcohol Rehab or Treatment Center	‑‑	0.5	‑‑	0.3	‑‑	0.6	‑‑	0.7
Some Other Place as an Inpatient	‑‑	0.6	‑‑	0.5	‑‑	0.5	‑‑	0.8
Outpatient	‑‑	20.3	‑‑	18.9	‑‑	21.1	‑‑	20.6
Mental Health Treatment Center	‑‑	3.1	‑‑	1.6	‑‑	4.3	‑‑	3.3
Drug or Alcohol Rehab or Treatment Center	‑‑	0.6	‑‑	0.4	‑‑	0.6	‑‑	0.7
Office of a Therapist, Psychologist, Psychiatrist, or Mental Health Professional	‑‑	14.0	‑‑	11.1	‑‑	14.9	‑‑	15.6
General Medical Clinic or Doctor’s Office	‑‑	5.3	‑‑	3.7	‑‑	6.2	‑‑	5.9
Hospital	‑‑	1.6	‑‑	1.1	‑‑	1.9	‑‑	1.9
School’s Health or Counseling Center	‑‑	11.4	‑‑	12.0	‑‑	12.1	‑‑	10.2
Some Other Place as an Outpatient	‑‑	1.4	‑‑	1.1	‑‑	1.6	‑‑	1.5
Outpatient, Other Than General Medical Clinic or Doctor’s Office	‑‑	19.6	‑‑	18.5	‑‑	20.4	‑‑	19.8
Prescription Medication	12.9	13.3	10.9	10.9	13.2	13.8	14.4	15.0
Telehealth Treatment²	13.1	13.0	11.6	10.0	13.1	14.4	14.3	14.5
Prison, Jail, or Juvenile Detention Center	1.2	1.1	1.2	1.3	1.4	0.9	1.0	1.1
OTHER SERVICES
Support Services
Support Group	6.7	7.4	8.5	6.8	5.9^b	8.7	5.9	6.6
Peer Support Specialist or Recovery Coach	3.1	2.7	3.2^a	2.0	2.9	3.6	3.1	2.3
Emergency Room/Department	2.6	2.3	2.6^b	1.2	2.3	2.7	3.0	2.7
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes treatment for mental health, emotions, or behavior through support group services, peer support specialist or recovery coach services, or treatment received in an emergency room/department. ² Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.6A – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Mental Health Treatment (2024)	Mental Health Treatment (2025)	Inpatient (2024)	Inpatient (2025)	Outpatient (2024)	Outpatient (2025)	Prescription Medication (2024)	Prescription Medication (2025)	Telehealth Treatment¹ (2024)	Telehealth Treatment¹ (2025)	Prison, Jail, or Juvenile Detention Center (2024)	Prison, Jail, or Juvenile Detention Center (2025)
TOTAL	‑‑	7,029	‑‑	639	‑‑	5,160	3,343	3,389	3,389	3,322	312	280
AGE GROUP
12‑13	‑‑	2,066	‑‑	106	‑‑	1,485	883	857	941	782	97	104
14‑15	‑‑	2,525	‑‑	257	‑‑	1,842	1,167	1,202	1,164	1,253	121	80
16‑17	‑‑	2,437	‑‑	276	‑‑	1,832	1,293	1,329	1,283	1,286	93	96
SEX
Male	‑‑	2,846	‑‑	225	‑‑	1,841	1,359	1,424	1,169	1,309	149	188
Female	‑‑	4,183	‑‑	414	‑‑	3,318	1,984	1,964	2,220	2,013	163^a	93
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	5,403	‑‑	507	‑‑	3,897	2,815	2,767	2,661	2,550	248	222
AIAN	‑‑	55	‑‑	11	‑‑	29	28	30	19	34	9	2
Asian	‑‑	240	‑‑	10	‑‑	191	52	60	98	113	1	*
Black or African American	‑‑	786	‑‑	78	‑‑	538	262	293	236	275	57	50
NHPI	‑‑	*	‑‑	*	‑‑	*	2	*	1	*	*	*
White	‑‑	3,877	‑‑	365	‑‑	2,784	2,313	2,197	2,116	1,932	156	139
Two or More Races	‑‑	441	‑‑	39	‑‑	352	157	187	191	196	24	20
Hispanic or Latino	‑‑	1,626	‑‑	133	‑‑	1,262	529	622	727	771	64	58
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.6B – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Mental Health Treatment (2024)	Mental Health Treatment (2025)	Inpatient (2024)	Inpatient (2025)	Outpatient (2024)	Outpatient (2025)	Prescription Medication (2024)	Prescription Medication (2025)	Telehealth Treatment¹ (2024)	Telehealth Treatment¹ (2025)	Prison, Jail, or Juvenile Detention Center (2024)	Prison, Jail, or Juvenile Detention Center (2025)
TOTAL	‑‑	27.6	‑‑	2.5	‑‑	20.3	12.9	13.3	13.1	13.0	1.2	1.1
AGE GROUP
12‑13	‑‑	26.3	‑‑	1.3	‑‑	18.9	10.9	10.9	11.6	10.0	1.2	1.3
14‑15	‑‑	29.0	‑‑	3.0	‑‑	21.1	13.2	13.8	13.1	14.4	1.4	0.9
16‑17	‑‑	27.4	‑‑	3.1	‑‑	20.6	14.4	15.0	14.3	14.5	1.0	1.1
SEX
Male	‑‑	21.9	‑‑	1.7	‑‑	14.2	10.2	11.0	8.8	10.1	1.1	1.4
Female	‑‑	33.6	‑‑	3.3	‑‑	26.7	15.7	15.8	17.5	16.2	1.3^a	0.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	29.0	‑‑	2.7	‑‑	20.9	14.8	14.9	14.0	13.7	1.3	1.2
AIAN	‑‑	20.3	‑‑	4.1	‑‑	10.7	13.5	10.9	9.2	12.4	4.3	0.8
Asian	‑‑	15.7	‑‑	0.7	‑‑	12.5	3.5	3.9	6.4	7.4	0.1	*
Black or African American	‑‑	23.0	‑‑	2.3	‑‑	15.8	7.4	8.6	6.6	8.0	1.6	1.5
NHPI	‑‑	*	‑‑	*	‑‑	*	2.4	*	1.0	*	*	*
White	‑‑	32.3	‑‑	3.0	‑‑	23.2	18.3	18.3	16.8	16.1	1.2	1.2
Two or More Races	‑‑	33.1	‑‑	3.0	‑‑	26.4	15.0	14.0	18.4	14.7	2.3	1.5
Hispanic or Latino	‑‑	23.8	‑‑	1.9	‑‑	18.5	7.7	9.1	10.5	11.3	0.9	0.9
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.7A – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Mental Health Treatment (2024)	Mental Health Treatment (2025)	Inpatient (2024)	Inpatient (2025)	Outpatient (2024)	Outpatient (2025)	Prescription Medication (2024)	Prescription Medication (2025)	Telehealth Treatment¹ (2024)	Telehealth Treatment¹ (2025)	Prison, Jail, or Juvenile Detention Center (2024)	Prison, Jail, or Juvenile Detention Center (2025)
TOTAL	‑‑	7,029	‑‑	639	‑‑	5,160	3,343	3,389	3,389	3,322	312	280
GEOGRAPHIC DIVISION
Northeast	‑‑	1,048	‑‑	87	‑‑	797	573	416	714	523	56	29
New England	‑‑	250	‑‑	9	‑‑	178	177	113	186	103	*	2
Middle Atlantic	‑‑	798	‑‑	78	‑‑	620	396	304	528	420	38	27
Midwest	‑‑	1,674	‑‑	170	‑‑	1,190	839	941	724	680	43	54
East North Central	‑‑	1,183	‑‑	98	‑‑	845	552	665	465	489	29	28
West North Central	‑‑	491	‑‑	72	‑‑	345	286	277	259	191	14	26
South	‑‑	2,714	‑‑	247	‑‑	1,912	1,295	1,427	1,134	1,276	153	163
South Atlantic	‑‑	1,434	‑‑	111	‑‑	1,021	598	758	627	720	65	67
East South Central	‑‑	460	‑‑	51	‑‑	321	257	257	197	201	18	32
West South Central	‑‑	821	‑‑	86	‑‑	570	440	412	310	355	71	63
West	‑‑	1,594	‑‑	135	‑‑	1,260	637	604	816	843	60	35
Mountain	‑‑	586	‑‑	50	‑‑	457	255	231	275	294	25	9
Pacific	‑‑	1,008	‑‑	85	‑‑	803	382	373	541	549	35	26
COUNTY TYPE
Large Metro	‑‑	3,882	‑‑	297	‑‑	2,936	1,742	1,702	2,034	2,003	134	134
Small Metro	‑‑	2,325	‑‑	233	‑‑	1,644	1,177	1,220	999	986	144	100
Nonmetro	‑‑	822	‑‑	110	‑‑	580	424	467	356	333	34	46
Urbanized	‑‑	256	‑‑	14	‑‑	174	149	149	130	114	17	10
Less Urbanized	‑‑	390	‑‑	63	‑‑	291	158	211	119	154	7	20
Completely Rural	‑‑	176	‑‑	33	‑‑	114	118	107	107	65	9	16
POVERTY LEVEL
Less Than 100%	‑‑	1,489	‑‑	200	‑‑	1,079	666	613	606	606	122	118
100‑199%	‑‑	1,602	‑‑	162	‑‑	1,111	557^b	812	612	699	59	70
200% or More	‑‑	3,938	‑‑	277	‑‑	2,969	2,120	1,963	2,171	2,017	131	93
HEALTH INSURANCE²
Private	‑‑	3,909	‑‑	237	‑‑	2,950	2,020	1,953	2,117	1,947	107	76
Medicaid/CHIP	‑‑	2,938	‑‑	379	‑‑	2,079	1,366	1,395	1,279	1,286	204	183
Other³	‑‑	420	‑‑	46	‑‑	317	176	191	157	177	19	24
No Coverage	‑‑	235	‑‑	35	‑‑	173	70	86	94	103	15	15
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.7B – Types and Locations of Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Mental Health Treatment (2024)	Mental Health Treatment (2025)	Inpatient (2024)	Inpatient (2025)	Outpatient (2024)	Outpatient (2025)	Prescription Medication (2024)	Prescription Medication (2025)	Telehealth Treatment¹ (2024)	Telehealth Treatment¹ (2025)	Prison, Jail, or Juvenile Detention Center (2024)	Prison, Jail, or Juvenile Detention Center (2025)
TOTAL	‑‑	27.6	‑‑	2.5	‑‑	20.3	12.9	13.3	13.1	13.0	1.2	1.1
GEOGRAPHIC DIVISION
Northeast	‑‑	26.2	‑‑	2.2	‑‑	20.0	14.0^a	10.4	17.5^a	13.1	1.4	0.7
New England	‑‑	24.5	‑‑	0.9	‑‑	17.4	17.0	11.1	17.8^a	10.1	*	0.2
Middle Atlantic	‑‑	26.8	‑‑	2.6	‑‑	20.8	13.0	10.2	17.4	14.1	1.2	0.9
Midwest	‑‑	31.5	‑‑	3.2	‑‑	22.4	15.5	17.7	13.4	12.8	0.8	1.0
East North Central	‑‑	33.2	‑‑	2.7	‑‑	23.7	15.1	18.6	12.7	13.7	0.8	0.8
West North Central	‑‑	28.2	‑‑	4.1	‑‑	19.8	16.3	15.9	14.7	11.0	0.8	1.5
South	‑‑	26.8	‑‑	2.4	‑‑	18.9	12.5	14.1	11.0	12.6	1.5	1.6
South Atlantic	‑‑	28.4	‑‑	2.2	‑‑	20.2	11.7^a	15.0	12.2	14.3	1.3	1.3
East South Central	‑‑	30.2	‑‑	3.4	‑‑	21.1	16.5	16.9	12.7	13.2	1.1	2.1
West South Central	‑‑	23.0	‑‑	2.4	‑‑	15.9	12.1	11.5	8.5	9.9	1.9	1.8
West	‑‑	26.5	‑‑	2.2	‑‑	21.0	10.4	10.0	13.3	14.0	1.0	0.6
Mountain	‑‑	28.6	‑‑	2.4	‑‑	22.3	12.4	11.2	13.4	14.3	1.2	0.4
Pacific	‑‑	25.4	‑‑	2.1	‑‑	20.3	9.4	9.4	13.3	13.9	0.9	0.7
COUNTY TYPE
Large Metro	‑‑	26.8	‑‑	2.0	‑‑	20.2	11.6	11.7	13.5	13.8	0.9	0.9
Small Metro	‑‑	28.3	‑‑	2.8	‑‑	20.0	14.5	14.9	12.3	12.0	1.8	1.2
Nonmetro	‑‑	29.9	‑‑	4.0	‑‑	21.1	15.2	17.0	12.8	12.1	1.2	1.7
Urbanized	‑‑	26.1	‑‑	1.5	‑‑	17.7	14.3	15.2	12.5	11.7	1.7	1.0
Less Urbanized	‑‑	33.5	‑‑	5.4	‑‑	25.0	15.4	18.1	11.6	13.2	0.7	1.7
Completely Rural	‑‑	29.4	‑‑	5.5	‑‑	19.1	16.3	17.8	14.8	10.8	1.3	2.7
POVERTY LEVEL
Less Than 100%	‑‑	26.3	‑‑	3.5	‑‑	19.1	12.1	10.9	11.0	10.7	2.2	2.1
100‑199%	‑‑	28.0	‑‑	2.8	‑‑	19.4	10.5^b	14.2	11.5	12.2	1.1	1.2
200% or More	‑‑	28.0	‑‑	2.0	‑‑	21.1	14.0	13.9	14.4	14.3	0.9	0.7
HEALTH INSURANCE²
Private	‑‑	28.2	‑‑	1.7	‑‑	21.3	13.8	14.1	14.5	14.0	0.7	0.5
Medicaid/CHIP	‑‑	28.0	‑‑	3.6	‑‑	19.8	13.1	13.3	12.2	12.3	2.0	1.7
Other³	‑‑	28.9	‑‑	3.1	‑‑	21.9	12.7	13.1	11.4	12.2	1.4	1.6
No Coverage	‑‑	20.9	‑‑	3.1	‑‑	15.4	5.8	7.6	7.7	9.2	1.3	1.4
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.8A – Received Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	7,029	‑‑	2,137	‑‑	1,677	‑‑	4,500
AGE GROUP
12‑13	‑‑	2,066	‑‑	431	‑‑	321	‑‑	1,459
14‑15	‑‑	2,525	‑‑	854	‑‑	679	‑‑	1,587
16‑17	‑‑	2,437	‑‑	851	‑‑	677	‑‑	1,453
SEX
Male	‑‑	2,846	‑‑	531	‑‑	420	‑‑	2,129
Female	‑‑	4,183	‑‑	1,606	‑‑	1,257	‑‑	2,371
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	5,403	‑‑	1,616	‑‑	1,307	‑‑	3,497
AIAN	‑‑	55	‑‑	*	‑‑	*	‑‑	36
Asian	‑‑	240	‑‑	*	‑‑	*	‑‑	170
Black or African American	‑‑	786	‑‑	165	‑‑	*	‑‑	582
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	3,877	‑‑	1,221	‑‑	1,005	‑‑	2,450
Two or More Races	‑‑	441	‑‑	156	‑‑	*	‑‑	257
Hispanic or Latino	‑‑	1,626	‑‑	521	‑‑	370	‑‑	1,003
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.8B – Received Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	27.6	‑‑	57.7	‑‑	61.7	‑‑	21.5
AGE GROUP
12‑13	‑‑	26.3	‑‑	58.7	‑‑	63.9	‑‑	21.6
14‑15	‑‑	29.0	‑‑	61.3	‑‑	66.0	‑‑	22.4
16‑17	‑‑	27.4	‑‑	53.9	‑‑	57.1	‑‑	20.6
SEX
Male	‑‑	21.9	‑‑	48.6	‑‑	53.3	‑‑	18.6
Female	‑‑	33.6	‑‑	61.4	‑‑	65.2	‑‑	25.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	29.0	‑‑	59.7	‑‑	64.3	‑‑	22.8
AIAN	‑‑	20.3	‑‑	*	‑‑	*	‑‑	15.3
Asian	‑‑	15.7	‑‑	*	‑‑	*	‑‑	12.7
Black or African American	‑‑	23.0	‑‑	43.8	‑‑	*	‑‑	19.8
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	32.3	‑‑	63.7	‑‑	68.1	‑‑	25.2
Two or More Races	‑‑	33.1	‑‑	66.7	‑‑	*	‑‑	24.6
Hispanic or Latino	‑‑	23.8	‑‑	52.2	‑‑	54.0	‑‑	18.0
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.9A – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	639	‑‑	273	‑‑	257	‑‑	299
AGE GROUP
12‑13	‑‑	106	‑‑	32	‑‑	31	‑‑	68
14‑15	‑‑	257	‑‑	134	‑‑	132	‑‑	114
16‑17	‑‑	276	‑‑	108	‑‑	94	‑‑	118
SEX
Male	‑‑	225	‑‑	39	‑‑	34	‑‑	145
Female	‑‑	414	‑‑	234	‑‑	223	‑‑	154
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	507	‑‑	218	‑‑	202	‑‑	239
AIAN	‑‑	11	‑‑	*	‑‑	*	‑‑	5
Asian	‑‑	10	‑‑	*	‑‑	*	‑‑	4
Black or African American	‑‑	78	‑‑	8	‑‑	6	‑‑	69
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	365	‑‑	180	‑‑	167	‑‑	139
Two or More Races	‑‑	39	‑‑	*	‑‑	*	‑‑	18
Hispanic or Latino	‑‑	133	‑‑	55	‑‑	54	‑‑	61
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.9B – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	2.5	‑‑	7.4	‑‑	9.5	‑‑	1.4
AGE GROUP
12‑13	‑‑	1.3	‑‑	4.3	‑‑	6.1	‑‑	1.0
14‑15	‑‑	3.0	‑‑	9.6	‑‑	12.8	‑‑	1.6
16‑17	‑‑	3.1	‑‑	6.8	‑‑	7.9	‑‑	1.7
SEX
Male	‑‑	1.7	‑‑	3.6	‑‑	4.3	‑‑	1.3
Female	‑‑	3.3	‑‑	8.9	‑‑	11.6	‑‑	1.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	2.7	‑‑	8.1	‑‑	10.0	‑‑	1.6
AIAN	‑‑	4.1	‑‑	*	‑‑	*	‑‑	2.3
Asian	‑‑	0.7	‑‑	*	‑‑	*	‑‑	0.3
Black or African American	‑‑	2.3	‑‑	2.1	‑‑	2.3	‑‑	2.4
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	3.0	‑‑	9.4	‑‑	11.3	‑‑	1.4
Two or More Races	‑‑	3.0	‑‑	*	‑‑	*	‑‑	1.7
Hispanic or Latino	‑‑	1.9	‑‑	5.5	‑‑	7.9	‑‑	1.1
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.10A – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	5,160	‑‑	1,793	‑‑	1,423	‑‑	3,060
AGE GROUP
12‑13	‑‑	1,485	‑‑	332	‑‑	244	‑‑	1,005
14‑15	‑‑	1,842	‑‑	711	‑‑	584	‑‑	1,076
16‑17	‑‑	1,832	‑‑	750	‑‑	594	‑‑	979
SEX
Male	‑‑	1,841	‑‑	414	‑‑	339	‑‑	1,300
Female	‑‑	3,318	‑‑	1,378	‑‑	1,084	‑‑	1,760
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	3,897	‑‑	1,347	‑‑	1,097	‑‑	2,325
AIAN	‑‑	29	‑‑	*	‑‑	*	‑‑	14
Asian	‑‑	191	‑‑	*	‑‑	*	‑‑	132
Black or African American	‑‑	538	‑‑	136	‑‑	*	‑‑	364
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	2,784	‑‑	1,031	‑‑	858	‑‑	1,604
Two or More Races	‑‑	352	‑‑	*	‑‑	*	‑‑	208
Hispanic or Latino	‑‑	1,262	‑‑	445	‑‑	326	‑‑	735
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.10B – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	20.3	‑‑	48.4	‑‑	52.4	‑‑	14.6
AGE GROUP
12‑13	‑‑	18.9	‑‑	45.2	‑‑	48.6	‑‑	14.8
14‑15	‑‑	21.1	‑‑	51.1	‑‑	56.8	‑‑	15.2
16‑17	‑‑	20.6	‑‑	47.5	‑‑	50.1	‑‑	13.9
SEX
Male	‑‑	14.2	‑‑	37.9	‑‑	43.0	‑‑	11.3
Female	‑‑	26.7	‑‑	52.7	‑‑	56.2	‑‑	18.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	20.9	‑‑	49.8	‑‑	54.0	‑‑	15.2
AIAN	‑‑	10.7	‑‑	*	‑‑	*	‑‑	6.1
Asian	‑‑	12.5	‑‑	*	‑‑	*	‑‑	9.8
Black or African American	‑‑	15.8	‑‑	36.0	‑‑	*	‑‑	12.4
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	23.2	‑‑	53.8	‑‑	58.1	‑‑	16.5
Two or More Races	‑‑	26.4	‑‑	*	‑‑	*	‑‑	20.0
Hispanic or Latino	‑‑	18.5	‑‑	44.6	‑‑	47.6	‑‑	13.2
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.11A – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	3,343	3,389	1,197	1,064	914	869	1,958	2,104
AGE GROUP
12‑13	883	857	155	161	119	148	658	609
14‑15	1,167	1,202	476	404	369	330	617	765
16‑17	1,293	1,329	566	499	426	391	683	729
SEX
Male	1,359	1,424	292	227	186	150	1,002	1,073
Female	1,984	1,964	905	837	728	719	955	1,030
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,815	2,767	997	847	740	699	1,662	1,758
AIAN	28	30	*	*	*	*	19	23
Asian	52	60	*	*	*	*	11	39
Black or African American	262	293	58^a	18	43^a	15	196	273
NHPI	2	*	*	*	*	*	2	*
White	2,313	2,197	826	740	611	615	1,356	1,325
Two or More Races	157	187	67	75	49	*	79	97
Hispanic or Latino	529	622	199	217	174	171	295	346
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.11B – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	12.9	13.3	31.2	28.7	32.2	32.0	9.3	10.1
AGE GROUP
12‑13	10.9	10.9	20.2	22.0	20.9	29.5	9.6	9.0
14‑15	13.2	13.8	34.9	29.0	37.0	32.1	8.6^a	10.8
16‑17	14.4	15.0	33.1	31.6	33.6	33.0	9.6	10.3
SEX
Male	10.2	11.0	27.0	20.8	25.3	19.0	8.5	9.4
Female	15.7	15.8	32.8	32.0	34.7	37.3	10.1	10.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.8	14.9	35.3	31.3	36.0	34.4	10.7	11.5
AIAN	13.5	10.9	*	*	*	*	10.4	10.0
Asian	3.5	3.9	*	*	*	*	0.9	2.9
Black or African American	7.4	8.6	16.0^a	4.7	16.5^a	5.6	6.3^a	9.3
NHPI	2.4	*	*	*	*	*	2.1	*
White	18.3	18.3	40.3	38.6	41.2	41.7	13.3	13.6
Two or More Races	15.0	14.0	30.0	32.0	29.9	*	10.2	9.3
Hispanic or Latino	7.7	9.1	19.6	21.8	22.4	24.9	5.3	6.2
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.12A – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	3,389	3,322	1,274	1,215	981	1,007	1,934	1,931
AGE GROUP
12‑13	941	782	247	215	192	171	609	511
14‑15	1,164	1,253	438	474	357	409	670	724
16‑17	1,283	1,286	589	526	432	427	656	696
SEX
Male	1,169	1,309	288	322	181	266	822	901
Female	2,220	2,013	986	893	801	741	1,112	1,030
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,661	2,550	989	915	747	779	1,526	1,499
AIAN	19	34	*	*	*	*	13	20
Asian	98	113	*	*	*	*	43	65
Black or African American	236	275	59	76	33^a	71	170	189
NHPI	1	*	*	*	*	*	<1	*
White	2,116	1,932	780	713	598	607	1,212	1,120
Two or More Races	191	196	93	77	68	*	88	104
Hispanic or Latino	727	771	284	300	234	228	408	432
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.12B – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	13.1	13.0	33.2	32.8	34.6	37.1	9.1	9.2
AGE GROUP
12‑13	11.6	10.0	32.1	29.3	33.9	34.0	8.9	7.6
14‑15	13.1	14.4	32.1	34.0	35.7	39.8	9.3	10.2
16‑17	14.3	14.5	34.5	33.4	34.1	36.1	9.2	9.9
SEX
Male	8.8	10.1	26.6	29.5	24.5	33.8	7.0	7.9
Female	17.5	16.2	35.7	34.2	38.2	38.4	11.8	10.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.0	13.7	35.0	33.8	36.3	38.3	9.8	9.8
AIAN	9.2	12.4	*	*	*	*	7.0	8.5
Asian	6.4	7.4	*	*	*	*	3.4	4.9
Black or African American	6.6	8.0	16.1	20.2	12.9^a	25.7	5.5	6.4
NHPI	1.0	*	*	*	*	*	0.5	*
White	16.8	16.1	38.1	37.2	40.3	41.1	11.9	11.5
Two or More Races	18.4	14.7	41.9	33.0	41.7	*	11.3	10.0
Hispanic or Latino	10.5	11.3	28.0	30.0	30.1	33.3	7.3	7.8
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.13A – Received Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	7,029	‑‑	2,137	‑‑	1,677	‑‑	4,500
GEOGRAPHIC DIVISION
Northeast	‑‑	1,048	‑‑	377	‑‑	314	‑‑	643
New England	‑‑	250	‑‑	*	‑‑	*	‑‑	175
Middle Atlantic	‑‑	798	‑‑	*	‑‑	*	‑‑	468
Midwest	‑‑	1,674	‑‑	492	‑‑	365	‑‑	1,091
East North Central	‑‑	1,183	‑‑	342	‑‑	247	‑‑	778
West North Central	‑‑	491	‑‑	150	‑‑	118	‑‑	313
South	‑‑	2,714	‑‑	776	‑‑	600	‑‑	1,763
South Atlantic	‑‑	1,434	‑‑	410	‑‑	309	‑‑	927
East South Central	‑‑	460	‑‑	*	‑‑	*	‑‑	279
West South Central	‑‑	821	‑‑	*	‑‑	*	‑‑	557
West	‑‑	1,594	‑‑	492	‑‑	397	‑‑	1,003
Mountain	‑‑	586	‑‑	158	‑‑	*	‑‑	410
Pacific	‑‑	1,008	‑‑	333	‑‑	259	‑‑	593
COUNTY TYPE
Large Metro	‑‑	3,882	‑‑	1,196	‑‑	946	‑‑	2,465
Small Metro	‑‑	2,325	‑‑	668	‑‑	535	‑‑	1,521
Nonmetro	‑‑	822	‑‑	272	‑‑	196	‑‑	514
Urbanized	‑‑	256	‑‑	83	‑‑	62	‑‑	167
Less Urbanized	‑‑	390	‑‑	*	‑‑	*	‑‑	252
Completely Rural	‑‑	176	‑‑	*	‑‑	*	‑‑	95
POVERTY LEVEL
Less Than 100%	‑‑	1,489	‑‑	489	‑‑	389	‑‑	904
100‑199%	‑‑	1,602	‑‑	415	‑‑	330	‑‑	1,073
200% or More	‑‑	3,938	‑‑	1,233	‑‑	957	‑‑	2,523
HEALTH INSURANCE⁶
Private	‑‑	3,909	‑‑	1,184	‑‑	908	‑‑	2,544
Medicaid/CHIP	‑‑	2,938	‑‑	868	‑‑	679	‑‑	1,883
Other⁷	‑‑	420	‑‑	*	‑‑	*	‑‑	221
No Coverage	‑‑	235	‑‑	*	‑‑	*	‑‑	146
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.13B – Received Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	27.6	‑‑	57.7	‑‑	61.7	‑‑	21.5
GEOGRAPHIC DIVISION
Northeast	‑‑	26.2	‑‑	63.4	‑‑	68.6	‑‑	19.4
New England	‑‑	24.5	‑‑	*	‑‑	*	‑‑	19.9
Middle Atlantic	‑‑	26.8	‑‑	*	‑‑	*	‑‑	19.2
Midwest	‑‑	31.5	‑‑	64.7	‑‑	65.0	‑‑	25.0
East North Central	‑‑	33.2	‑‑	65.8	‑‑	64.3	‑‑	26.8
West North Central	‑‑	28.2	‑‑	62.4	‑‑	66.6	‑‑	21.6
South	‑‑	26.8	‑‑	53.1	‑‑	56.8	‑‑	21.2
South Atlantic	‑‑	28.4	‑‑	56.2	‑‑	61.4	‑‑	22.5
East South Central	‑‑	30.2	‑‑	*	‑‑	*	‑‑	23.5
West South Central	‑‑	23.0	‑‑	*	‑‑	*	‑‑	18.5
West	‑‑	26.5	‑‑	55.4	‑‑	62.0	‑‑	20.4
Mountain	‑‑	28.6	‑‑	49.9	‑‑	*	‑‑	24.6
Pacific	‑‑	25.4	‑‑	58.4	‑‑	63.6	‑‑	18.3
COUNTY TYPE
Large Metro	‑‑	26.8	‑‑	58.1	‑‑	63.1	‑‑	20.6
Small Metro	‑‑	28.3	‑‑	54.6	‑‑	58.9	‑‑	22.8
Nonmetro	‑‑	29.9	‑‑	64.3	‑‑	63.0	‑‑	22.8
Urbanized	‑‑	26.1	‑‑	59.1	‑‑	60.3	‑‑	20.2
Less Urbanized	‑‑	33.5	‑‑	*	‑‑	*	‑‑	26.3
Completely Rural	‑‑	29.4	‑‑	*	‑‑	*	‑‑	20.1
POVERTY LEVEL
Less Than 100%	‑‑	26.3	‑‑	60.0	‑‑	60.8	‑‑	19.7
100‑199%	‑‑	28.0	‑‑	51.8	‑‑	58.0	‑‑	22.8
200% or More	‑‑	28.0	‑‑	59.0	‑‑	63.5	‑‑	21.7
HEALTH INSURANCE⁶
Private	‑‑	28.2	‑‑	58.2	‑‑	62.8	‑‑	22.2
Medicaid/CHIP	‑‑	28.0	‑‑	57.0	‑‑	59.1	‑‑	22.0
Other⁷	‑‑	28.9	‑‑	*	‑‑	*	‑‑	20.5
No Coverage	‑‑	20.9	‑‑	*	‑‑	*	‑‑	15.4
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.14A – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	639	‑‑	273	‑‑	257	‑‑	299
GEOGRAPHIC DIVISION
Northeast	‑‑	87	‑‑	51	‑‑	51	‑‑	25
New England	‑‑	9	‑‑	3	‑‑	3	‑‑	6
Middle Atlantic	‑‑	78	‑‑	48	‑‑	48	‑‑	19
Midwest	‑‑	170	‑‑	84	‑‑	79	‑‑	75
East North Central	‑‑	98	‑‑	53	‑‑	48	‑‑	43
West North Central	‑‑	72	‑‑	31	‑‑	*	‑‑	32
South	‑‑	247	‑‑	89	‑‑	79	‑‑	131
South Atlantic	‑‑	111	‑‑	32	‑‑	31	‑‑	61
East South Central	‑‑	51	‑‑	*	‑‑	*	‑‑	28
West South Central	‑‑	86	‑‑	*	‑‑	*	‑‑	42
West	‑‑	135	‑‑	48	‑‑	48	‑‑	69
Mountain	‑‑	50	‑‑	24	‑‑	24	‑‑	23
Pacific	‑‑	85	‑‑	24	‑‑	24	‑‑	46
COUNTY TYPE
Large Metro	‑‑	297	‑‑	115	‑‑	113	‑‑	140
Small Metro	‑‑	233	‑‑	101	‑‑	96	‑‑	116
Nonmetro	‑‑	110	‑‑	57	‑‑	*	‑‑	44
Urbanized	‑‑	14	‑‑	6	‑‑	*	‑‑	8
Less Urbanized	‑‑	63	‑‑	*	‑‑	*	‑‑	26
Completely Rural	‑‑	33	‑‑	*	‑‑	*	‑‑	10
POVERTY LEVEL
Less Than 100%	‑‑	200	‑‑	81	‑‑	79	‑‑	100
100‑199%	‑‑	162	‑‑	51	‑‑	43	‑‑	92
200% or More	‑‑	277	‑‑	140	‑‑	135	‑‑	108
HEALTH INSURANCE⁶
Private	‑‑	237	‑‑	108	‑‑	108	‑‑	103
Medicaid/CHIP	‑‑	379	‑‑	153	‑‑	138	‑‑	190
Other⁷	‑‑	46	‑‑	23	‑‑	22	‑‑	17
No Coverage	‑‑	35	‑‑	*	‑‑	*	‑‑	5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.14B – Received Mental Health Treatment as an Inpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	2.5	‑‑	7.4	‑‑	9.5	‑‑	1.4
GEOGRAPHIC DIVISION
Northeast	‑‑	2.2	‑‑	8.6	‑‑	11.1	‑‑	0.7
New England	‑‑	0.9	‑‑	3.0	‑‑	3.7	‑‑	0.6
Middle Atlantic	‑‑	2.6	‑‑	9.8	‑‑	12.7	‑‑	0.8
Midwest	‑‑	3.2	‑‑	11.1	‑‑	14.0	‑‑	1.7
East North Central	‑‑	2.7	‑‑	10.2	‑‑	12.4	‑‑	1.5
West North Central	‑‑	4.1	‑‑	12.9	‑‑	*	‑‑	2.2
South	‑‑	2.4	‑‑	6.1	‑‑	7.5	‑‑	1.6
South Atlantic	‑‑	2.2	‑‑	4.4	‑‑	6.1	‑‑	1.5
East South Central	‑‑	3.4	‑‑	*	‑‑	*	‑‑	2.3
West South Central	‑‑	2.4	‑‑	*	‑‑	*	‑‑	1.4
West	‑‑	2.2	‑‑	5.4	‑‑	7.5	‑‑	1.4
Mountain	‑‑	2.4	‑‑	7.6	‑‑	10.3	‑‑	1.4
Pacific	‑‑	2.1	‑‑	4.2	‑‑	5.8	‑‑	1.4
COUNTY TYPE
Large Metro	‑‑	2.0	‑‑	5.6	‑‑	7.5	‑‑	1.2
Small Metro	‑‑	2.8	‑‑	8.2	‑‑	10.6	‑‑	1.7
Nonmetro	‑‑	4.0	‑‑	13.5	‑‑	*	‑‑	1.9
Urbanized	‑‑	1.5	‑‑	4.6	‑‑	*	‑‑	0.9
Less Urbanized	‑‑	5.4	‑‑	*	‑‑	*	‑‑	2.7
Completely Rural	‑‑	5.5	‑‑	*	‑‑	*	‑‑	2.1
POVERTY LEVEL
Less Than 100%	‑‑	3.5	‑‑	10.0	‑‑	12.4	‑‑	2.2
100‑199%	‑‑	2.8	‑‑	6.4	‑‑	7.5	‑‑	1.9
200% or More	‑‑	2.0	‑‑	6.7	‑‑	8.9	‑‑	0.9
HEALTH INSURANCE⁶
Private	‑‑	1.7	‑‑	5.3	‑‑	7.5	‑‑	0.9
Medicaid/CHIP	‑‑	3.6	‑‑	10.0	‑‑	12.0	‑‑	2.2
Other⁷	‑‑	3.1	‑‑	8.1	‑‑	10.0	‑‑	1.6
No Coverage	‑‑	3.1	‑‑	*	‑‑	*	‑‑	0.5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.15A – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	5,160	‑‑	1,793	‑‑	1,423	‑‑	3,060
GEOGRAPHIC DIVISION
Northeast	‑‑	797	‑‑	323	‑‑	270	‑‑	448
New England	‑‑	178	‑‑	*	‑‑	*	‑‑	113
Middle Atlantic	‑‑	620	‑‑	262	‑‑	*	‑‑	335
Midwest	‑‑	1,190	‑‑	421	‑‑	320	‑‑	709
East North Central	‑‑	845	‑‑	286	‑‑	215	‑‑	513
West North Central	‑‑	345	‑‑	135	‑‑	105	‑‑	196
South	‑‑	1,912	‑‑	615	‑‑	465	‑‑	1,162
South Atlantic	‑‑	1,021	‑‑	319	‑‑	237	‑‑	626
East South Central	‑‑	321	‑‑	*	‑‑	*	‑‑	169
West South Central	‑‑	570	‑‑	171	‑‑	*	‑‑	367
West	‑‑	1,260	‑‑	434	‑‑	369	‑‑	741
Mountain	‑‑	457	‑‑	143	‑‑	*	‑‑	297
Pacific	‑‑	803	‑‑	291	‑‑	245	‑‑	444
COUNTY TYPE
Large Metro	‑‑	2,936	‑‑	977	‑‑	780	‑‑	1,762
Small Metro	‑‑	1,644	‑‑	591	‑‑	479	‑‑	962
Nonmetro	‑‑	580	‑‑	225	‑‑	164	‑‑	336
Urbanized	‑‑	174	‑‑	61	‑‑	47	‑‑	110
Less Urbanized	‑‑	291	‑‑	*	‑‑	*	‑‑	173
Completely Rural	‑‑	114	‑‑	*	‑‑	*	‑‑	53
POVERTY LEVEL
Less Than 100%	‑‑	1,079	‑‑	377	‑‑	299	‑‑	640
100‑199%	‑‑	1,111	‑‑	321	‑‑	262	‑‑	698
200% or More	‑‑	2,969	‑‑	1,094	‑‑	862	‑‑	1,722
HEALTH INSURANCE⁶
Private	‑‑	2,950	‑‑	1,039	‑‑	796	‑‑	1,767
Medicaid/CHIP	‑‑	2,079	‑‑	675	‑‑	545	‑‑	1,259
Other⁷	‑‑	317	‑‑	*	‑‑	*	‑‑	154
No Coverage	‑‑	173	‑‑	*	‑‑	*	‑‑	94
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.15B – Received Mental Health Treatment as an Outpatient in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	‑‑	20.3	‑‑	48.4	‑‑	52.4	‑‑	14.6
GEOGRAPHIC DIVISION
Northeast	‑‑	20.0	‑‑	54.3	‑‑	58.8	‑‑	13.5
New England	‑‑	17.4	‑‑	*	‑‑	*	‑‑	12.9
Middle Atlantic	‑‑	20.8	‑‑	54.1	‑‑	*	‑‑	13.8
Midwest	‑‑	22.4	‑‑	55.4	‑‑	57.0	‑‑	16.3
East North Central	‑‑	23.7	‑‑	54.9	‑‑	55.9	‑‑	17.7
West North Central	‑‑	19.8	‑‑	56.3	‑‑	59.3	‑‑	13.5
South	‑‑	18.9	‑‑	42.0	‑‑	44.0	‑‑	13.9
South Atlantic	‑‑	20.2	‑‑	43.7	‑‑	47.1	‑‑	15.2
East South Central	‑‑	21.1	‑‑	*	‑‑	*	‑‑	14.2
West South Central	‑‑	15.9	‑‑	36.8	‑‑	*	‑‑	12.2
West	‑‑	21.0	‑‑	48.9	‑‑	57.6	‑‑	15.1
Mountain	‑‑	22.3	‑‑	45.2	‑‑	*	‑‑	17.8
Pacific	‑‑	20.3	‑‑	51.0	‑‑	60.1	‑‑	13.7
COUNTY TYPE
Large Metro	‑‑	20.2	‑‑	47.5	‑‑	52.0	‑‑	14.7
Small Metro	‑‑	20.0	‑‑	48.3	‑‑	52.8	‑‑	14.4
Nonmetro	‑‑	21.1	‑‑	53.1	‑‑	52.8	‑‑	14.9
Urbanized	‑‑	17.7	‑‑	43.8	‑‑	45.9	‑‑	13.3
Less Urbanized	‑‑	25.0	‑‑	*	‑‑	*	‑‑	18.1
Completely Rural	‑‑	19.1	‑‑	*	‑‑	*	‑‑	11.2
POVERTY LEVEL
Less Than 100%	‑‑	19.1	‑‑	46.3	‑‑	46.7	‑‑	13.9
100‑199%	‑‑	19.4	‑‑	40.2	‑‑	46.0	‑‑	14.8
200% or More	‑‑	21.1	‑‑	52.3	‑‑	57.2	‑‑	14.8
HEALTH INSURANCE⁶
Private	‑‑	21.3	‑‑	51.1	‑‑	55.0	‑‑	15.4
Medicaid/CHIP	‑‑	19.8	‑‑	44.3	‑‑	47.5	‑‑	14.7
Other⁷	‑‑	21.9	‑‑	*	‑‑	*	‑‑	14.3
No Coverage	‑‑	15.4	‑‑	*	‑‑	*	‑‑	9.9
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.16A – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	3,343	3,389	1,197	1,064	914	869	1,958	2,104
GEOGRAPHIC DIVISION
Northeast	573	416	184	164	139	153	353^a	237
New England	177	113	*	*	*	*	115	78
Middle Atlantic	396	304	132	133	105	*	238	159
Midwest	839	941	259	287	199	226	531	601
East North Central	552	665	155	209	118	156	364	419
West North Central	286	277	104	78	81	70	166	181
South	1,295	1,427	457	411	336	320	783	908
South Atlantic	598	758	167	205	133	165	397	496
East South Central	257	257	98	*	91	*	154	155
West South Central	440	412	192	116	112	*	231	257
West	637	604	298	202	240	170	291	358
Mountain	255	231	113^a	65	86	63	112	161
Pacific	382	373	184	138	153	107	179	197
COUNTY TYPE
Large Metro	1,742	1,702	595	546	444	445	1,049	1,032
Small Metro	1,177	1,220	459	364	363	312	659	786
Nonmetro	424	467	143	155	107	112	249	286
Urbanized	149	149	*	48	*	34	83	96
Less Urbanized	158	211	*	*	*	*	98	137
Completely Rural	118	107	*	*	*	*	69	53
POVERTY LEVEL
Less Than 100%	666	613	183	221	145	182	437	339
100‑199%	557^b	812	196	220	169	175	321^b	527
200% or More	2,120	1,963	818^a	623	599	513	1,199	1,237
HEALTH INSURANCE⁶
Private	2,020	1,953	747	613	566	492	1,177	1,241
Medicaid/CHIP	1,366	1,395	479	406	384	328	783	871
Other⁷	176	191	*	*	29	*	117	85
No Coverage	70	86	*	*	*	*	44	34
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.16B – Received Mental Health Treatment through Prescription Medication in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	12.9	13.3	31.2	28.7	32.2	32.0	9.3	10.1
GEOGRAPHIC DIVISION
Northeast	14.0^a	10.4	32.6	27.7	31.0	33.3	10.6^a	7.1
New England	17.0	11.1	*	*	*	*	13.2	8.8
Middle Atlantic	13.0	10.2	30.9	27.4	30.8	*	9.6	6.5
Midwest	15.5	17.7	31.6	37.7	34.4	40.2	12.1	13.8
East North Central	15.1	18.6	30.1	40.1	32.3	40.5	12.2	14.4
West North Central	16.3	15.9	34.3	32.5	38.0	39.4	11.9	12.5
South	12.5	14.1	30.8	28.1	30.3	30.4	9.2	10.9
South Atlantic	11.7^a	15.0	25.5	28.1	26.9	32.7	9.2	12.0
East South Central	16.5	16.9	35.7	*	39.1	*	12.4	13.0
West South Central	12.1	11.5	34.6	24.8	29.3	*	7.8	8.5
West	10.4	10.0	30.5	22.8	34.3	26.6	5.9	7.3
Mountain	12.4	11.2	32.4^a	20.4	35.2	26.9	7.0	9.6
Pacific	9.4	9.4	29.4	24.1	33.8	26.3	5.4	6.1
COUNTY TYPE
Large Metro	11.6	11.7	29.6	26.5	29.4	29.7	8.4	8.6
Small Metro	14.5	14.9	32.9	29.7	35.5	34.4	10.2	11.8
Nonmetro	15.2	17.0	32.8	36.6	35.7	36.1	10.9	12.7
Urbanized	14.3	15.2	*	34.2	*	33.3	9.6	11.6
Less Urbanized	15.4	18.1	*	*	*	*	11.3	14.3
Completely Rural	16.3	17.8	*	*	*	*	12.4	11.2
POVERTY LEVEL
Less Than 100%	12.1	10.9	23.9	27.1	25.7	28.4	9.6	7.4
100‑199%	10.5^b	14.2	25.5	27.5	27.9	30.6	7.4^b	11.2
200% or More	14.0	13.9	35.5	29.8	36.1	34.0	9.8	10.7
HEALTH INSURANCE⁶
Private	13.8	14.1	33.7	30.1	34.7	34.1	9.9	10.8
Medicaid/CHIP	13.1	13.3	30.3	26.6	31.9	28.6	9.3	10.2
Other⁷	12.7	13.1	*	*	26.4	*	9.9	7.9
No Coverage	5.8	7.6	*	*	*	*	4.4	3.6
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.17A – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	3,389	3,322	1,274	1,215	981	1,007	1,934	1,931
GEOGRAPHIC DIVISION
Northeast	714	523	267	231	205	*	408	283
New England	186	103	*	27	*	*	108	73
Middle Atlantic	528	420	196	*	151	*	300	210
Midwest	724	680	250	253	199	200	440	388
East North Central	465	489	143	187	116	136	299	274
West North Central	259	191	107	67	83	64	142	114
South	1,134	1,276	431	414	322	350	661	774
South Atlantic	627	720	215	226	157	182	391	436
East South Central	197	201	86	69	80	*	107	122
West South Central	310	355	130	*	84	*	163	216
West	816	843	325	317	256	256	425	487
Mountain	275	294	129	95	101	85	110	195
Pacific	541	549	196	222	154	172	315	292
COUNTY TYPE
Large Metro	2,034	2,003	715	744	540	606	1,215	1,168
Small Metro	999	986	429	339	341	294	511	584
Nonmetro	356	333	129	132	100	107	208	180
Urbanized	130	114	*	*	*	*	74	74
Less Urbanized	119	154	*	*	*	*	77	84
Completely Rural	107	65	*	*	*	*	56^a	23
POVERTY LEVEL
Less Than 100%	606	606	208	237	153	203	366	326
100‑199%	612	699	215	253	167	205	357	405
200% or More	2,171	2,017	850	725	661	599	1,212	1,200
HEALTH INSURANCE⁶
Private	2,117	1,947	788	714	632	589	1,220	1,132
Medicaid/CHIP	1,279	1,286	489	456	370	374	710	760
Other⁷	157	177	*	81	27	*	107	89
No Coverage	94	103	*	*	*	*	49	61
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.17B – Received Mental Health Treatment through Telehealth in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	13.1	13.0	33.2	32.8	34.6	37.1	9.1	9.2
GEOGRAPHIC DIVISION
Northeast	17.5^a	13.1	47.4	38.8	45.6	*	12.2^a	8.5
New England	17.8^a	10.1	*	24.9	*	*	12.4	8.3
Middle Atlantic	17.4	14.1	45.8	*	44.2	*	12.1	8.6
Midwest	13.4	12.8	30.6	33.3	34.4	35.5	10.1	8.9
East North Central	12.7	13.7	27.7	35.9	31.7	35.3	10.0	9.4
West North Central	14.7	11.0	35.5	27.8	39.0	36.0	10.1	7.9
South	11.0	12.6	29.1	28.3	29.0	33.2	7.8	9.3
South Atlantic	12.2	14.3	33.0	31.0	31.9	36.1	9.1	10.6
East South Central	12.7	13.2	31.4	25.9	34.6	*	8.6	10.3
West South Central	8.5	9.9	23.4	*	21.9	*	5.5	7.2
West	13.3	14.0	33.3	35.7	36.6	40.0	8.7	9.9
Mountain	13.4	14.3	36.9	30.0	41.2	36.1	6.8^a	11.7
Pacific	13.3	13.9	31.3	38.9	34.1	42.2	9.5	9.0
COUNTY TYPE
Large Metro	13.5	13.8	35.6	36.1	35.7	40.4	9.8	9.8
Small Metro	12.3	12.0	30.8	27.7	33.3	32.4	7.9	8.7
Nonmetro	12.8	12.1	29.6	31.1	33.5	34.5	9.1	8.0
Urbanized	12.5	11.7	*	*	*	*	8.6	8.9
Less Urbanized	11.6	13.2	*	*	*	*	9.0	8.7
Completely Rural	14.8	10.8	*	*	*	*	10.1^a	4.9
POVERTY LEVEL
Less Than 100%	11.0	10.7	27.2	29.1	26.9	31.8	8.0	7.1
100‑199%	11.5	12.2	28.1	31.6	27.6	36.0	8.2	8.6
200% or More	14.4	14.3	36.8	34.7	39.8	39.7	9.9	10.3
HEALTH INSURANCE⁶
Private	14.5	14.0	35.5	35.1	38.7	40.7	10.2	9.9
Medicaid/CHIP	12.2	12.3	31.0	29.9	30.7	32.6	8.4	8.9
Other⁷	11.4	12.2	*	28.3	24.1	*	9.0	8.3
No Coverage	7.7	9.2	*	*	*	*	4.9	6.4
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. ⁶ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁷ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.18A – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	1,779	‑‑	320	‑‑	1,454	‑‑	16,382
AGE GROUP
12‑13	‑‑	423	‑‑	73	‑‑	349	‑‑	5,242
14‑15	‑‑	590	‑‑	126	‑‑	465	‑‑	5,506
16‑17	‑‑	766	‑‑	121	‑‑	640	‑‑	5,634
SEX
Male	‑‑	569	‑‑	122	‑‑	447	‑‑	9,424
Female	‑‑	1,211	‑‑	198	‑‑	1,007	‑‑	6,957
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	1,232	‑‑	226	‑‑	1,001	‑‑	11,812
AIAN	‑‑	9	‑‑	*	‑‑	8	‑‑	201
Asian	‑‑	111	‑‑	10	‑‑	101	‑‑	1,167
Black or African American	‑‑	286	‑‑	58	‑‑	228	‑‑	2,308
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	773	‑‑	153	‑‑	615	‑‑	7,267
Two or More Races	‑‑	53	‑‑	4	‑‑	50	‑‑	806
Hispanic or Latino	‑‑	547	‑‑	94	‑‑	453	‑‑	4,570
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.18B – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	9.8	‑‑	1.8	‑‑	8.0	‑‑	90.2
AGE GROUP
12‑13	‑‑	7.5	‑‑	1.3	‑‑	6.2	‑‑	92.5
14‑15	‑‑	9.7	‑‑	2.1	‑‑	7.6	‑‑	90.3
16‑17	‑‑	12.0	‑‑	1.9	‑‑	10.0	‑‑	88.0
SEX
Male	‑‑	5.7	‑‑	1.2	‑‑	4.5	‑‑	94.3
Female	‑‑	14.8	‑‑	2.4	‑‑	12.3	‑‑	85.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	9.4	‑‑	1.7	‑‑	7.7	‑‑	90.6
AIAN	‑‑	4.4	‑‑	*	‑‑	3.7	‑‑	95.6
Asian	‑‑	8.7	‑‑	0.8	‑‑	7.9	‑‑	91.3
Black or African American	‑‑	11.0	‑‑	2.2	‑‑	8.8	‑‑	89.0
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	9.6	‑‑	1.9	‑‑	7.6	‑‑	90.4
Two or More Races	‑‑	6.2	‑‑	0.4	‑‑	5.8	‑‑	93.8
Hispanic or Latino	‑‑	10.7	‑‑	1.8	‑‑	8.8	‑‑	89.3
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.19A – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	651	‑‑	107	‑‑	544	‑‑	910
AGE GROUP
12‑13	‑‑	*	‑‑	28	‑‑	*	‑‑	*
14‑15	‑‑	221	‑‑	31	‑‑	189	‑‑	313
16‑17	‑‑	281	‑‑	48	‑‑	233	‑‑	443
SEX
Male	‑‑	168	‑‑	27	‑‑	141	‑‑	386
Female	‑‑	483	‑‑	80	‑‑	403	‑‑	524
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	465	‑‑	78	‑‑	387	‑‑	617
AIAN	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Asian	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Black or African American	‑‑	*	‑‑	18	‑‑	*	‑‑	*
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	295	‑‑	54	‑‑	241	‑‑	396
Two or More Races	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Hispanic or Latino	‑‑	185	‑‑	29	‑‑	156	‑‑	293
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.19B – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	41.7	‑‑	6.8	‑‑	34.8	‑‑	58.3
AGE GROUP
12‑13	‑‑	*	‑‑	9.3	‑‑	*	‑‑	*
14‑15	‑‑	41.3	‑‑	5.8	‑‑	35.3	‑‑	58.7
16‑17	‑‑	38.8	‑‑	6.6	‑‑	32.2	‑‑	61.2
SEX
Male	‑‑	30.3	‑‑	4.9	‑‑	25.3	‑‑	69.7
Female	‑‑	47.9	‑‑	7.9	‑‑	40.0	‑‑	52.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	43.0	‑‑	7.2	‑‑	35.7	‑‑	57.0
AIAN	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Asian	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Black or African American	‑‑	*	‑‑	8.3	‑‑	*	‑‑	*
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	42.7	‑‑	7.8	‑‑	34.7	‑‑	57.3
Two or More Races	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Hispanic or Latino	‑‑	38.7	‑‑	6.0	‑‑	32.7	‑‑	61.3
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.20A – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	484	‑‑	96	‑‑	388	‑‑	552
AGE GROUP
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	165	‑‑	28	‑‑	138	‑‑	184
16‑17	‑‑	216	‑‑	41	‑‑	175	‑‑	290
SEX
Male	‑‑	113	‑‑	23	‑‑	90	‑‑	252
Female	‑‑	371	‑‑	73	‑‑	298	‑‑	301
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	348	‑‑	68	‑‑	280	‑‑	374
AIAN	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Asian	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Black or African American	‑‑	*	‑‑	*	‑‑	*	‑‑	*
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	236	‑‑	48	‑‑	188	‑‑	235
Two or More Races	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Hispanic or Latino	‑‑	*	‑‑	29	‑‑	*	‑‑	*
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.20B – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Demographic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	46.7	‑‑	9.3	‑‑	37.4	‑‑	53.3
AGE GROUP
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	47.3	‑‑	8.0	‑‑	39.3	‑‑	52.7
16‑17	‑‑	42.7	‑‑	8.0	‑‑	34.6	‑‑	57.3
SEX
Male	‑‑	31.0	‑‑	6.3	‑‑	24.6	‑‑	69.0
Female	‑‑	55.3	‑‑	10.9	‑‑	44.4	‑‑	44.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	48.2	‑‑	9.3	‑‑	38.8	‑‑	51.8
AIAN	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Asian	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Black or African American	‑‑	*	‑‑	*	‑‑	*	‑‑	*
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	50.1	‑‑	10.2	‑‑	39.9	‑‑	49.9
Two or More Races	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Hispanic or Latino	‑‑	*	‑‑	9.1	‑‑	*	‑‑	*
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.21A – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Geographic/Socioeconomic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	1,779	‑‑	320	‑‑	1,454	‑‑	16,382
GEOGRAPHIC DIVISION
Northeast	‑‑	275	‑‑	49	‑‑	226	‑‑	2,651
New England	‑‑	60	‑‑	*	‑‑	46	‑‑	697
Middle Atlantic	‑‑	215	‑‑	35	‑‑	179	‑‑	1,954
Midwest	‑‑	310	‑‑	57	‑‑	254	‑‑	3,271
East North Central	‑‑	188	‑‑	23	‑‑	166	‑‑	2,160
West North Central	‑‑	122	‑‑	34	‑‑	88	‑‑	1,111
South	‑‑	724	‑‑	134	‑‑	589	‑‑	6,579
South Atlantic	‑‑	358	‑‑	58	‑‑	300	‑‑	3,190
East South Central	‑‑	143	‑‑	23	‑‑	119	‑‑	896
West South Central	‑‑	223	‑‑	53	‑‑	169	‑‑	2,492
West	‑‑	470	‑‑	80	‑‑	385	‑‑	3,882
Mountain	‑‑	145	‑‑	18	‑‑	128	‑‑	1,302
Pacific	‑‑	325	‑‑	62	‑‑	258	‑‑	2,580
COUNTY TYPE
Large Metro	‑‑	1,049	‑‑	205	‑‑	839	‑‑	9,452
Small Metro	‑‑	563	‑‑	94	‑‑	469	‑‑	5,187
Nonmetro	‑‑	167	‑‑	21	‑‑	146	‑‑	1,743
Urbanized	‑‑	57	‑‑	5	‑‑	52	‑‑	665
Less Urbanized	‑‑	66	‑‑	13	‑‑	53	‑‑	704
Completely Rural	‑‑	44	‑‑	3	‑‑	41	‑‑	373
POVERTY LEVEL
Less Than 100%	‑‑	388	‑‑	58	‑‑	330	‑‑	3,687
100‑199%	‑‑	344	‑‑	83	‑‑	261	‑‑	3,698
200% or More	‑‑	1,046	‑‑	178	‑‑	863	‑‑	8,997
HEALTH INSURANCE¹
Private	‑‑	1,088	‑‑	200	‑‑	884	‑‑	8,754
Medicaid/CHIP	‑‑	645	‑‑	131	‑‑	513	‑‑	6,747
Other²	‑‑	86	‑‑	14	‑‑	71	‑‑	916
No Coverage	‑‑	62	‑‑	16	‑‑	47	‑‑	819
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.21B – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment in Past Year
Geographic/Socioeconomic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	9.8	‑‑	1.8	‑‑	8.0	‑‑	90.2
GEOGRAPHIC DIVISION
Northeast	‑‑	9.4	‑‑	1.7	‑‑	7.7	‑‑	90.6
New England	‑‑	8.0	‑‑	*	‑‑	6.1	‑‑	92.0
Middle Atlantic	‑‑	9.9	‑‑	1.6	‑‑	8.3	‑‑	90.1
Midwest	‑‑	8.7	‑‑	1.6	‑‑	7.1	‑‑	91.3
East North Central	‑‑	8.0	‑‑	1.0	‑‑	7.0	‑‑	92.0
West North Central	‑‑	9.9	‑‑	2.8	‑‑	7.1	‑‑	90.1
South	‑‑	9.9	‑‑	1.8	‑‑	8.0	‑‑	90.1
South Atlantic	‑‑	10.1	‑‑	1.6	‑‑	8.4	‑‑	89.9
East South Central	‑‑	13.7	‑‑	2.2	‑‑	11.3	‑‑	86.3
West South Central	‑‑	8.2	‑‑	1.9	‑‑	6.2	‑‑	91.8
West	‑‑	10.8	‑‑	1.8	‑‑	8.8	‑‑	89.2
Mountain	‑‑	10.1	‑‑	1.2	‑‑	8.8	‑‑	89.9
Pacific	‑‑	11.2	‑‑	2.1	‑‑	8.8	‑‑	88.8
COUNTY TYPE
Large Metro	‑‑	10.0	‑‑	1.9	‑‑	8.0	‑‑	90.0
Small Metro	‑‑	9.8	‑‑	1.6	‑‑	8.1	‑‑	90.2
Nonmetro	‑‑	8.8	‑‑	1.1	‑‑	7.6	‑‑	91.2
Urbanized	‑‑	7.9	‑‑	0.7	‑‑	7.1	‑‑	92.1
Less Urbanized	‑‑	8.6	‑‑	1.7	‑‑	6.9	‑‑	91.4
Completely Rural	‑‑	10.5	‑‑	0.6	‑‑	9.9	‑‑	89.5
POVERTY LEVEL
Less Than 100%	‑‑	9.5	‑‑	1.4	‑‑	8.1	‑‑	90.5
100‑199%	‑‑	8.5	‑‑	2.1	‑‑	6.4	‑‑	91.5
200% or More	‑‑	10.4	‑‑	1.8	‑‑	8.6	‑‑	89.6
HEALTH INSURANCE¹
Private	‑‑	11.1	‑‑	2.0	‑‑	9.0	‑‑	88.9
Medicaid/CHIP	‑‑	8.7	‑‑	1.8	‑‑	6.9	‑‑	91.3
Other²	‑‑	8.6	‑‑	1.4	‑‑	7.1	‑‑	91.4
No Coverage	‑‑	7.1	‑‑	1.8	‑‑	5.3	‑‑	92.9
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.22A – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year
Geographic/Socioeconomic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	651	‑‑	107	‑‑	544	‑‑	910
GEOGRAPHIC DIVISION
Northeast	‑‑	*	‑‑	10	‑‑	*	‑‑	*
New England	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Middle Atlantic	‑‑	*	‑‑	9	‑‑	*	‑‑	*
Midwest	‑‑	101	‑‑	21	‑‑	80	‑‑	167
East North Central	‑‑	*	‑‑	10	‑‑	*	‑‑	*
West North Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
South	‑‑	292	‑‑	48	‑‑	244	‑‑	390
South Atlantic	‑‑	131	‑‑	21	‑‑	110	‑‑	185
East South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West	‑‑	172	‑‑	28	‑‑	144	‑‑	225
Mountain	‑‑	*	‑‑	4	‑‑	*	‑‑	*
Pacific	‑‑	*	‑‑	*	‑‑	*	‑‑	*
COUNTY TYPE
Large Metro	‑‑	344	‑‑	63	‑‑	281	‑‑	511
Small Metro	‑‑	233	‑‑	33	‑‑	199	‑‑	323
Nonmetro	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Less Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Completely Rural	‑‑	*	‑‑	*	‑‑	*	‑‑	*
POVERTY LEVEL
Less Than 100%	‑‑	*	‑‑	*	‑‑	*	‑‑	*
100‑199%	‑‑	133	‑‑	30	‑‑	103	‑‑	249
200% or More	‑‑	382	‑‑	66	‑‑	316	‑‑	470
HEALTH INSURANCE¹
Private	‑‑	364	‑‑	65	‑‑	299	‑‑	479
Medicaid/CHIP	‑‑	271	‑‑	47	‑‑	224	‑‑	384
Other²	‑‑	*	‑‑	8	‑‑	*	‑‑	*
No Coverage	‑‑	*	‑‑	*	‑‑	*	‑‑	*
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.22B – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode Who Did Not Receive Mental Health Treatment in Past Year
Geographic/Socioeconomic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	41.7	‑‑	6.8	‑‑	34.8	‑‑	58.3
GEOGRAPHIC DIVISION
Northeast	‑‑	*	‑‑	4.7	‑‑	*	‑‑	*
New England	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Middle Atlantic	‑‑	*	‑‑	4.8	‑‑	*	‑‑	*
Midwest	‑‑	37.6	‑‑	7.8	‑‑	29.8	‑‑	62.4
East North Central	‑‑	*	‑‑	5.8	‑‑	*	‑‑	*
West North Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
South	‑‑	42.8	‑‑	7.0	‑‑	35.6	‑‑	57.2
South Atlantic	‑‑	41.4	‑‑	6.5	‑‑	34.6	‑‑	58.6
East South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West	‑‑	43.3	‑‑	7.0	‑‑	36.3	‑‑	56.7
Mountain	‑‑	*	‑‑	2.6	‑‑	*	‑‑	*
Pacific	‑‑	*	‑‑	*	‑‑	*	‑‑	*
COUNTY TYPE
Large Metro	‑‑	40.3	‑‑	7.4	‑‑	32.8	‑‑	59.7
Small Metro	‑‑	41.9	‑‑	6.0	‑‑	35.9	‑‑	58.1
Nonmetro	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Less Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Completely Rural	‑‑	*	‑‑	*	‑‑	*	‑‑	*
POVERTY LEVEL
Less Than 100%	‑‑	*	‑‑	*	‑‑	*	‑‑	*
100‑199%	‑‑	34.8	‑‑	7.8	‑‑	26.9	‑‑	65.2
200% or More	‑‑	44.8	‑‑	7.8	‑‑	36.9	‑‑	55.2
HEALTH INSURANCE¹
Private	‑‑	43.2	‑‑	7.6	‑‑	35.4	‑‑	56.8
Medicaid/CHIP	‑‑	41.4	‑‑	7.1	‑‑	34.2	‑‑	58.6
Other²	‑‑	*	‑‑	6.7	‑‑	*	‑‑	*
No Coverage	‑‑	*	‑‑	*	‑‑	*	‑‑	*
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.23A – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Geographic/Socioeconomic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	484	‑‑	96	‑‑	388	‑‑	552
GEOGRAPHIC DIVISION
Northeast	‑‑	*	‑‑	*	‑‑	*	‑‑	*
New England	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Middle Atlantic	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Midwest	‑‑	*	‑‑	17	‑‑	63	‑‑	*
East North Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West North Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
South	‑‑	226	‑‑	44	‑‑	182	‑‑	229
South Atlantic	‑‑	*	‑‑	17	‑‑	*	‑‑	*
East South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Mountain	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Pacific	‑‑	*	‑‑	*	‑‑	*	‑‑	*
COUNTY TYPE
Large Metro	‑‑	255	‑‑	56	‑‑	199	‑‑	295
Small Metro	‑‑	*	‑‑	32	‑‑	133	‑‑	*
Nonmetro	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Less Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Completely Rural	‑‑	*	‑‑	*	‑‑	*	‑‑	*
POVERTY LEVEL
Less Than 100%	‑‑	*	‑‑	*	‑‑	*	‑‑	*
100‑199%	‑‑	*	‑‑	29	‑‑	60	‑‑	*
200% or More	‑‑	281	‑‑	57	‑‑	224	‑‑	268
HEALTH INSURANCE¹
Private	‑‑	254	‑‑	61	‑‑	193	‑‑	280
Medicaid/CHIP	‑‑	222	‑‑	45	‑‑	177	‑‑	248
Other²	‑‑	*	‑‑	*	‑‑	*	‑‑	*
No Coverage	‑‑	*	‑‑	*	‑‑	*	‑‑	*
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.23B – Perceived Unmet Need for Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Among People Aged 12 to 17 with Past Year Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment in Past Year
Geographic/Socioeconomic Characteristic	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)	Did Not Perceive Need for Mental Health Treatment (2024)	Did Not Perceive Need for Mental Health Treatment (2025)
TOTAL	‑‑	46.7	‑‑	9.3	‑‑	37.4	‑‑	53.3
GEOGRAPHIC DIVISION
Northeast	‑‑	*	‑‑	*	‑‑	*	‑‑	*
New England	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Middle Atlantic	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Midwest	‑‑	*	‑‑	8.7	‑‑	32.0	‑‑	*
East North Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West North Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
South	‑‑	49.6	‑‑	9.7	‑‑	39.9	‑‑	50.4
South Atlantic	‑‑	*	‑‑	8.6	‑‑	*	‑‑	*
East South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West South Central	‑‑	*	‑‑	*	‑‑	*	‑‑	*
West	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Mountain	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Pacific	‑‑	*	‑‑	*	‑‑	*	‑‑	*
COUNTY TYPE
Large Metro	‑‑	46.4	‑‑	10.1	‑‑	36.2	‑‑	53.6
Small Metro	‑‑	*	‑‑	8.6	‑‑	35.9	‑‑	*
Nonmetro	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Less Urbanized	‑‑	*	‑‑	*	‑‑	*	‑‑	*
Completely Rural	‑‑	*	‑‑	*	‑‑	*	‑‑	*
POVERTY LEVEL
Less Than 100%	‑‑	*	‑‑	*	‑‑	*	‑‑	*
100‑199%	‑‑	*	‑‑	12.1	‑‑	25.4	‑‑	*
200% or More	‑‑	51.2	‑‑	10.4	‑‑	40.8	‑‑	48.8
HEALTH INSURANCE¹
Private	‑‑	47.6	‑‑	11.4	‑‑	36.1	‑‑	52.4
Medicaid/CHIP	‑‑	47.3	‑‑	9.6	‑‑	37.7	‑‑	52.7
Other²	‑‑	*	‑‑	*	‑‑	*	‑‑	*
No Coverage	‑‑	*	‑‑	*	‑‑	*	‑‑	*
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.24A – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year; by Past Year Treatment‑Seeking Behavior, Numbers in Thousands, 2024 and 2025
Reason Did Not Receive Mental Health Treatment	Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year
Reason Did Not Receive Mental Health Treatment	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)
Thought It Would Cost Too Much	‑‑	428	‑‑	76	‑‑	348
Did Not Have Health Insurance Coverage for Mental Health Treatment	‑‑	105	‑‑	13	‑‑	92
Health Insurance Would Not Pay Enough of Costs for Treatment	‑‑	104	‑‑	*	‑‑	77
Did Not Know How or Where to Get Treatment	‑‑	718	‑‑	109	‑‑	603
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	‑‑	379	‑‑	78	‑‑	295
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	‑‑	95	‑‑	*	‑‑	59
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them	‑‑	221	‑‑	37	‑‑	184
Did Not Have Enough Time for Treatment	‑‑	449	‑‑	72	‑‑	371
Worried That Information Would Not Be Kept Private	‑‑	789	‑‑	100	‑‑	683
Worried about What People Would Think or Say if They Got Treatment	‑‑	944	‑‑	104	‑‑	835
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	‑‑	156	‑‑	28	‑‑	127
Not Ready to Start Treatment	‑‑	658	‑‑	84	‑‑	575
Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own	‑‑	1,312	‑‑	*	‑‑	1,133
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	‑‑	556	‑‑	70	‑‑	485
Afraid of Being Committed to Hospital or Forced into Treatment against Their Will	‑‑	455	‑‑	70	‑‑	380
Thought They Would Be Told They Needed to Take Medication	‑‑	417	‑‑	63	‑‑	349
Did Not Think Treatment Would Help Them	‑‑	744	‑‑	104	‑‑	635
Thought No One Would Care if They Got Better	‑‑	472	‑‑	82	‑‑	384
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving treatment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.24B – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year; by Past Year Treatment‑Seeking Behavior, Percentages, 2024 and 2025
Reason Did Not Receive Mental Health Treatment	Among People Aged 12 to 17 Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year
Reason Did Not Receive Mental Health Treatment	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)
Thought It Would Cost Too Much	‑‑	24.3	‑‑	23.8	‑‑	24.1
Did Not Have Health Insurance Coverage for Mental Health Treatment	‑‑	6.2	‑‑	4.2	‑‑	6.7
Health Insurance Would Not Pay Enough of Costs for Treatment	‑‑	6.1	‑‑	*	‑‑	5.5
Did Not Know How or Where to Get Treatment	‑‑	40.5	‑‑	34.2	‑‑	41.7
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	‑‑	21.8	‑‑	25.0	‑‑	20.8
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	‑‑	5.5	‑‑	*	‑‑	4.2
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them	‑‑	12.7	‑‑	11.9	‑‑	12.9
Did Not Have Enough Time for Treatment	‑‑	26.1	‑‑	23.0	‑‑	26.5
Worried That Information Would Not Be Kept Private	‑‑	45.0	‑‑	31.9	‑‑	47.7
Worried about What People Would Think or Say if They Got Treatment	‑‑	53.4	‑‑	32.6	‑‑	57.9
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	‑‑	8.9	‑‑	9.0	‑‑	8.9
Not Ready to Start Treatment	‑‑	38.6	‑‑	26.8	‑‑	41.4
Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own	‑‑	75.4	‑‑	*	‑‑	79.6
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	‑‑	32.1	‑‑	22.5	‑‑	34.3
Afraid of Being Committed to Hospital or Forced into Treatment against Their Will	‑‑	26.2	‑‑	22.2	‑‑	26.8
Thought They Would Be Told They Needed to Take Medication	‑‑	23.9	‑‑	20.2	‑‑	24.4
Did Not Think Treatment Would Help Them	‑‑	42.9	‑‑	34.2	‑‑	44.6
Thought No One Would Care if They Got Better	‑‑	27.3	‑‑	26.9	‑‑	27.1
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving treatment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.25A – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year; by Past Year Treatment‑Seeking Behavior, Numbers in Thousands, 2024 and 2025
Reason Did Not Receive Mental Health Treatment	Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year
Reason Did Not Receive Mental Health Treatment	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)
Thought It Would Cost Too Much	‑‑	174	‑‑	*	‑‑	136
Did Not Have Health Insurance Coverage for Mental Health Treatment	‑‑	67	‑‑	*	‑‑	61
Health Insurance Would Not Pay Enough of Costs for Treatment	‑‑	56	‑‑	5	‑‑	50
Did Not Know How or Where to Get Treatment	‑‑	281	‑‑	*	‑‑	221
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	‑‑	163	‑‑	*	‑‑	120
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	‑‑	45	‑‑	*	‑‑	34
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them	‑‑	93	‑‑	*	‑‑	73
Did Not Have Enough Time for Treatment	‑‑	153	‑‑	*	‑‑	125
Worried That Information Would Not Be Kept Private	‑‑	361	‑‑	*	‑‑	314
Worried about What People Would Think or Say if They Got Treatment	‑‑	406	‑‑	*	‑‑	342
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	‑‑	69	‑‑	*	‑‑	45
Not Ready to Start Treatment	‑‑	259	‑‑	*	‑‑	215
Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own	‑‑	564	‑‑	*	‑‑	481
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	‑‑	261	‑‑	*	‑‑	217
Afraid of Being Committed to Hospital or Forced into Treatment against Their Will	‑‑	216	‑‑	*	‑‑	174
Thought They Would Be Told They Needed to Take Medication	‑‑	217	‑‑	*	‑‑	175
Did Not Think Treatment Would Help Them	‑‑	339	‑‑	*	‑‑	273
Thought No One Would Care if They Got Better	‑‑	258	‑‑	*	‑‑	193
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving treatment data were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.25B – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year; by Past Year Treatment‑Seeking Behavior, Percentages, 2024 and 2025
Reason Did Not Receive Mental Health Treatment	Among People Aged 12 to 17 with Major Depressive Episode Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year
Reason Did Not Receive Mental Health Treatment	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)
Thought It Would Cost Too Much	‑‑	26.9	‑‑	*	‑‑	25.2
Did Not Have Health Insurance Coverage for Mental Health Treatment	‑‑	10.7	‑‑	*	‑‑	11.7
Health Insurance Would Not Pay Enough of Costs for Treatment	‑‑	9.0	‑‑	5.1	‑‑	9.8
Did Not Know How or Where to Get Treatment	‑‑	43.2	‑‑	*	‑‑	40.8
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	‑‑	25.4	‑‑	*	‑‑	22.4
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	‑‑	7.0	‑‑	*	‑‑	6.4
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them	‑‑	14.7	‑‑	*	‑‑	13.9
Did Not Have Enough Time for Treatment	‑‑	24.3	‑‑	*	‑‑	23.8
Worried That Information Would Not Be Kept Private	‑‑	57.2	‑‑	*	‑‑	60.0
Worried about What People Would Think or Say if They Got Treatment	‑‑	62.8	‑‑	*	‑‑	63.4
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	‑‑	10.8	‑‑	*	‑‑	8.5
Not Ready to Start Treatment	‑‑	41.1	‑‑	*	‑‑	40.9
Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own	‑‑	87.4	‑‑	*	‑‑	89.3
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	‑‑	41.7	‑‑	*	‑‑	41.9
Afraid of Being Committed to Hospital or Forced into Treatment against Their Will	‑‑	34.5	‑‑	*	‑‑	33.6
Thought They Would Be Told They Needed to Take Medication	‑‑	34.4	‑‑	*	‑‑	33.2
Did Not Think Treatment Would Help Them	‑‑	53.9	‑‑	*	‑‑	52.4
Thought No One Would Care if They Got Better	‑‑	41.4	‑‑	*	‑‑	37.4
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving treatment data were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.26A – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year; by Past Year Treatment‑Seeking Behavior, Numbers in Thousands, 2024 and 2025
Reason Did Not Receive Mental Health Treatment	Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year
Reason Did Not Receive Mental Health Treatment	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)
Thought It Would Cost Too Much	‑‑	121	‑‑	*	‑‑	90
Did Not Have Health Insurance Coverage for Mental Health Treatment	‑‑	47	‑‑	*	‑‑	42
Health Insurance Would Not Pay Enough of Costs for Treatment	‑‑	33	‑‑	*	‑‑	28
Did Not Know How or Where to Get Treatment	‑‑	198	‑‑	*	‑‑	144
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	‑‑	121	‑‑	*	‑‑	83
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	‑‑	39	‑‑	*	‑‑	28
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them	‑‑	78	‑‑	*	‑‑	61
Did Not Have Enough Time for Treatment	‑‑	121	‑‑	*	‑‑	101
Worried That Information Would Not Be Kept Private	‑‑	267	‑‑	*	‑‑	228
Worried about What People Would Think or Say if They Got Treatment	‑‑	310	‑‑	*	‑‑	256
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	‑‑	59	‑‑	*	‑‑	41
Not Ready to Start Treatment	‑‑	204	‑‑	*	‑‑	168
Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own	‑‑	412	‑‑	*	‑‑	337
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	‑‑	218	‑‑	*	‑‑	*
Afraid of Being Committed to Hospital or Forced into Treatment against Their Will	‑‑	166	‑‑	*	‑‑	133
Thought They Would Be Told They Needed to Take Medication	‑‑	170	‑‑	*	‑‑	133
Did Not Think Treatment Would Help Them	‑‑	259	‑‑	*	‑‑	199
Thought No One Would Care if They Got Better	‑‑	212	‑‑	*	‑‑	152
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving treatment data were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.26B – Detailed Reasons for Not Receiving Mental Health Treatment in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year; by Past Year Treatment‑Seeking Behavior, Percentages, 2024 and 2025
Reason Did Not Receive Mental Health Treatment	Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment Who Did Not Receive Mental Health Treatment and Had a Perceived Unmet Need for Mental Health Treatment in Past Year
Reason Did Not Receive Mental Health Treatment	Any Perceived Unmet Need (2024)	Any Perceived Unmet Need (2025)	Sought Treatment (2024)	Sought Treatment (2025)	Did Not Seek Treatment but Thought Should Get Treatment (2024)	Did Not Seek Treatment but Thought Should Get Treatment (2025)
Thought It Would Cost Too Much	‑‑	25.1	‑‑	*	‑‑	23.2
Did Not Have Health Insurance Coverage for Mental Health Treatment	‑‑	10.1	‑‑	*	‑‑	11.2
Health Insurance Would Not Pay Enough of Costs for Treatment	‑‑	7.1	‑‑	*	‑‑	7.4
Did Not Know How or Where to Get Treatment	‑‑	41.0	‑‑	*	‑‑	37.2
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to	‑‑	25.1	‑‑	*	‑‑	21.5
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to	‑‑	8.0	‑‑	*	‑‑	7.3
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them	‑‑	16.2	‑‑	*	‑‑	16.1
Did Not Have Enough Time for Treatment	‑‑	25.4	‑‑	*	‑‑	26.3
Worried That Information Would Not Be Kept Private	‑‑	57.5	‑‑	*	‑‑	61.9
Worried about What People Would Think or Say if They Got Treatment	‑‑	64.7	‑‑	*	‑‑	66.7
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children	‑‑	12.3	‑‑	*	‑‑	10.8
Not Ready to Start Treatment	‑‑	43.0	‑‑	*	‑‑	44.0
Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own	‑‑	86.0	‑‑	*	‑‑	88.0
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment	‑‑	46.0	‑‑	*	‑‑	*
Afraid of Being Committed to Hospital or Forced into Treatment against Their Will	‑‑	35.5	‑‑	*	‑‑	35.9
Thought They Would Be Told They Needed to Take Medication	‑‑	36.5	‑‑	*	‑‑	35.8
Did Not Think Treatment Would Help Them	‑‑	55.9	‑‑	*	‑‑	54.3
Thought No One Would Care if They Got Better	‑‑	45.8	‑‑	*	‑‑	41.3
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reasons for not receiving treatment data were excluded. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.27A – Substance Use in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment, Numbers in Thousands, 2024 and 2025
Substance	Had MDE^1,2 (2024)	Had MDE^1,2 (2025)	Had MDE with Severe Impairment^1,3,4 (2024)	Had MDE with Severe Impairment^1,3,4 (2025)	Had No MDE^1,2 (2024)	Had No MDE^1,2 (2025)
ILLICIT DRUGS⁵	‑‑	803	‑‑	624	‑‑	1,900
Marijuana	961^b	649	767^b	496	1,648	1,471
Cocaine	22	30	21	22	45^a	6
Crack	6	<1	6	*	1	*
Heroin	4	*	4	*	5	<1
Hallucinogens	155	127	115	102	247	209
LSD	54	36	41	23	56	39
Psilocybin	120	88	100	67	188	153
Ecstasy	26	37	23	29	31	11
Inhalants⁶	‑‑	122	‑‑	91	‑‑	208
Methamphetamine	7	11	6	11	49^a	1
Misuse of Prescription Psychotherapeutics	217	190	173	159	407	360
Pain Relievers	122	107	112	85	287	271
Prescription Opioids	102	101	92	79	277	260
Stimulants	67	89	49	68	129	101
Tranquilizers or Sedatives	93	59	65	58	77	68
Tranquilizers	68	52	48	52	57	53
Sedatives	31	11	22	11	32	20
Benzodiazepines	49	48	46	48	57	59
Misuse of Opioids⁵	106	101	97	79	277	260
Misuse of Central Nervous System Stimulants	84	98	65	77	197^a	108
Illicit Drugs Other Than Marijuana^5,6,7	‑‑	354	‑‑	282	‑‑	692
NICOTINE PRODUCTS⁸	1,090^a	851	840^a	630	2,151	2,137
Tobacco Products⁸	414^a	299	317^b	194	786	843
Cigarettes	295	245	224	152	485	601
Daily Cigarettes	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
Smokeless Tobacco	91	63	70	41	185	181
Cigars	137^a	77	113^a	55	315	280
Pipe Tobacco⁸	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
Nicotine Vaping	1,031^a	811	804^a	614	1,968	1,919
ALCOHOL	1,190	1,005	929	785	2,956	2,656
Binge Alcohol Use	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
Heavy Alcohol Use	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	106	101	97	79	309	289
Illegally Made Fentanyl	*	*	*	*	38	34
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Some 2024 estimates may differ from previously published estimates due to updates. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. ⁵ Does not include illegally made fentanyl (IMF). ⁶ Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁷ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁸ Information about past year use of pipe tobacco was not collected. Nicotine product use (including tobacco product use) in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.27B – Substance Use in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment, Percentages, 2024 and 2025
Substance	Had MDE^1,2 (2024)	Had MDE^1,2 (2025)	Had MDE with Severe Impairment^1,3,4 (2024)	Had MDE with Severe Impairment^1,3,4 (2025)	Had No MDE^1,2 (2024)	Had No MDE^1,2 (2025)
ILLICIT DRUGS⁵	‑‑	21.7	‑‑	23.0	‑‑	9.1
Marijuana	25.0^b	17.5	27.0^b	18.3	7.8	7.0
Cocaine	0.6	0.8	0.7	0.8	0.2^a	<0.1
Crack	0.2	<0.1	0.2	*	<0.1	*
Heroin	0.1	*	0.2	*	<0.1	<0.1
Hallucinogens	4.0	3.4	4.1	3.8	1.2	1.0
LSD	1.4	1.0	1.4	0.9	0.3	0.2
Psilocybin	3.1	2.4	3.5	2.5	0.9	0.7
Ecstasy	0.7	1.0	0.8	1.1	0.1	0.1
Inhalants⁶	‑‑	3.3	‑‑	3.3	‑‑	1.0
Methamphetamine	0.2	0.3	0.2	0.4	0.2^a	<0.1
Misuse of Prescription Psychotherapeutics	5.6	5.1	6.1	5.8	1.9	1.7
Pain Relievers	3.2	2.9	3.9	3.1	1.4	1.3
Prescription Opioids	2.7	2.7	3.3	2.9	1.3	1.2
Stimulants	1.7	2.4	1.7	2.5	0.6	0.5
Tranquilizers or Sedatives	2.4	1.6	2.3	2.2	0.4	0.3
Tranquilizers	1.8	1.4	1.7	1.9	0.3	0.3
Sedatives	0.8	0.3	0.8	0.4	0.2	0.1
Benzodiazepines	1.3	1.3	1.6	1.8	0.3	0.3
Misuse of Opioids⁵	2.8	2.7	3.4	2.9	1.3	1.2
Misuse of Central Nervous System Stimulants	2.2	2.6	2.3	2.8	0.9^a	0.5
Illicit Drugs Other Than Marijuana^5,6,7	‑‑	9.6	‑‑	10.4	‑‑	3.3
NICOTINE PRODUCTS⁸	28.4^a	23.0	29.6^a	23.2	10.2	10.2
Tobacco Products⁸	10.8	8.1	11.2^b	7.1	3.7	4.0
Cigarettes	7.7	6.6	7.9	5.6	2.3	2.9
Daily Cigarettes	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
Smokeless Tobacco	2.4	1.7	2.5	1.5	0.9	0.9
Cigars	3.6^a	2.1	4.0^a	2.0	1.5	1.3
Pipe Tobacco⁸	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
Nicotine Vaping	26.8^a	21.9	28.4^a	22.6	9.3	9.2
ALCOHOL	31.0	27.1	32.8	28.9	14.0	12.7
Binge Alcohol Use	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
Heavy Alcohol Use	‑‑	‑‑	‑‑	‑‑	‑‑	‑‑
MISUSE OF OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL	2.8	2.7	3.4	2.9	1.5	1.4
Illegally Made Fentanyl	*	*	*	*	0.2	0.2
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Some 2024 estimates may differ from previously published estimates due to updates. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. ⁵ Does not include illegally made fentanyl (IMF). ⁶ Changes were made to the inhalant questions in 2025. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁷ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁸ Information about past year use of pipe tobacco was not collected. Nicotine product use (including tobacco product use) in the past year excludes past year pipe tobacco use but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.28A – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Age Group and Sex, Numbers in Thousands, 2024 and 2025
Substance Use Disorder/Age Group	Total (2024)	Total (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
SUBSTANCE USE DISORDER	792^a	604	247	188	545^a	415
12‑13	*	*	*	*	*	*
14‑15	217	216	*	*	166	140
16‑17	506^b	312	191^b	87	315	225
Drug Use Disorder	696^a	533	217	162	479	371
12‑13	*	*	*	*	*	*
14‑15	197	196	*	*	147	*
16‑17	436^b	271	161^b	65	275	207
Alcohol Use Disorder	328^a	218	76	49	251	168
12‑13	*	*	*	*	*	*
14‑15	*	*	*	*	*	*
16‑17	220^b	117	*	35	*	*
NO SUBSTANCE USE DISORDER	3,047	3,102	834	904	2,213	2,198
12‑13	698	659	156	138	542	521
14‑15	1,149	1,177	294	328	855	849
16‑17	1,201	1,266	384	438	816	828
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.28B – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Age Group and Sex, Percentages, 2024 and 2025
Substance Use Disorder/Age Group	Total (2024)	Total (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
SUBSTANCE USE DISORDER	41.0^a	33.9	30.0	21.6	49.2	45.7
12‑13	*	*	*	*	*	*
14‑15	41.5	38.3	*	*	47.1	49.6
16‑17	41.9^a	31.4	32.7^a	18.2	50.6	43.6
Drug Use Disorder	42.8	37.1	30.7	23.0	52.3	50.5
12‑13	*	*	*	*	*	*
14‑15	44.0	41.6	*	*	49.2	*
16‑17	43.7	35.0	33.1^a	17.5	54.0	50.9
Alcohol Use Disorder	44.3^a	32.5	30.9^a	16.4	51.0	45.6
12‑13	*	*	*	*	*	*
14‑15	*	*	*	*	*	*
16‑17	45.1^b	27.5	*	16.6	*	*
NO SUBSTANCE USE DISORDER	13.2	13.6	7.0	7.7	20.0	19.7
12‑13	9.4	9.1	4.1	3.7	15.0	14.6
14‑15	14.3	14.9	6.9	8.2	22.7	21.6
16‑17	15.7	16.6	9.7	11.0	22.1	22.7
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.29A – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Age Group and Sex, Numbers in Thousands, 2024 and 2025
Substance Use Disorder/Age Group	Total (2024)	Total (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
SUBSTANCE USE DISORDER	632^a	467	204	128	428	339
12‑13	*	*	*	*	*	*
14‑15	158	168	*	*	126	*
16‑17	413^b	241	166^b	56	247	184
Drug Use Disorder	557^a	411	181	104	376	307
12‑13	*	*	*	*	*	*
14‑15	145	155	*	*	112	*
16‑17	357^b	208	143^b	37	214	171
Alcohol Use Disorder	265^a	168	61	43	204^a	125
12‑13	*	*	*	*	*	*
14‑15	60	*	*	*	*	*
16‑17	177^b	89	*	31	121^a	58
NO SUBSTANCE USE DISORDER	2,202	2,250	531	660	1,671	1,590
12‑13	507	445	102	104	405	341
14‑15	842	860	182	229	660	631
16‑17	854	945	248	327	606	618
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.29B – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Age Group and Sex, Percentages, 2024 and 2025
Substance Use Disorder/Age Group	Total (2024)	Total (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
SUBSTANCE USE DISORDER	32.8^a	26.3	24.7^a	14.7	38.9	37.3
12‑13	*	*	*	*	*	*
14‑15	30.3	30.0	*	*	35.6	*
16‑17	34.4^a	24.2	28.4^b	11.8	40.1	35.7
Drug Use Disorder	34.4	28.6	25.5^a	14.8	41.4	41.9
12‑13	*	*	*	*	*	*
14‑15	32.2	33.1	*	*	37.6	*
16‑17	36.0	26.8	29.3^b	9.9	42.5	42.2
Alcohol Use Disorder	35.9^a	25.1	24.9	14.4	41.4	33.8
12‑13	*	*	*	*	*	*
14‑15	30.8	*	*	*	*	*
16‑17	36.3^a	21.0	*	15.0	41.0	26.7
NO SUBSTANCE USE DISORDER	9.6	9.9	4.4	5.7	15.1	14.3
12‑13	6.8	6.1	2.7	2.8	11.2	9.6
14‑15	10.5	10.9	4.3	5.8	17.6	16.0
16‑17	11.2	12.4	6.3	8.2	16.4	17.0
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.30A – Substance Use Disorder in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Age Group and Sex, Numbers in Thousands, 2024 and 2025
MDE/Demographic Characteristic	No Substance Use Disorder (2024)	No Substance Use Disorder (2025)	Substance Use Disorder
MDE/Demographic Characteristic	No Substance Use Disorder (2024)	No Substance Use Disorder (2025)	Drugs (2024)	Drugs (2025)	Marijuana (2024)	Marijuana (2025)	Opioids (2024)	Opioids (2025)	Alcohol (2024)	Alcohol (2025)	Both Drugs and Alcohol (2024)	Both Drugs and Alcohol (2025)	Substance Use Disorder (2024)	Substance Use Disorder (2025)
TOTAL¹	23,928	23,578	1,705	1,511	1,219	1,118	267	207	775	710	456	344	2,024	1,877
MDE^2,3	3,047	3,102	696^a	533	511^a	377	107	62	328^a	218	231	147	792^a	604
Age Group
12‑13	698	659	62	65	30	21	27	16	30	26	23	*	69	76
14‑15	1,149	1,177	197	196	135	154	33	13	77	74	57	55	217	216
16‑17	1,201	1,266	436^b	271	346^b	202	47	32	220^b	117	151^a	76	506^b	312
Sex
Male	834	904	217	162	154	114	28	12	76	49	46	23	247	188
Female	2,213	2,198	479	371	357	263	79	50	251	168	185	124	545^a	415
MDE with Severe Impairment^4,5	2,202	2,250	557^a	411	409	292	94	54	265^a	168	191^a	112	632^a	467
Age Group
12‑13	507	445	56	47	27	19	24	10	28	*	22	5	61	58
14‑15	842	860	145	155	93	122	32	13	60	63	47	50	158	168
16‑17	854	945	357^b	208	289^b	151	38	31	177^b	89	122^a	57	413^b	241
Sex
Male	531	660	181	104	127	72	27	7	61	43	38	19	204	128
Female	1,671	1,590	376	307	282	220	67	47	204^a	125	153	93	428	339
NO MDE^2,3	20,020	19,734	928	905	656	687	150	108	411	452	199	181	1,141	1,176
Age Group
12‑13	6,717	6,622	116	124	29	60	44	25	24	37	5	15	135	146
14‑15	6,861	6,738	251	276	155	196	51	38	119	105	64	34	306	347
16‑17	6,442	6,374	561	505	471	430	55	45	268	309	130	132	700	683
Sex
Male	11,157	10,786	492	542	353	415	48	81	170	251	83	111	579	682
Female	8,863	8,948	437	363	302	271	102^b	27	241	201	115	70	563	494
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown past year MDE data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.30B – Substance Use Disorder in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment and Age Group and Sex, Percentages, 2024 and 2025
MDE/Demographic Characteristic	No Substance Use Disorder (2024)	No Substance Use Disorder (2025)	Substance Use Disorder
MDE/Demographic Characteristic	No Substance Use Disorder (2024)	No Substance Use Disorder (2025)	Drugs (2024)	Drugs (2025)	Marijuana (2024)	Marijuana (2025)	Opioids (2024)	Opioids (2025)	Alcohol (2024)	Alcohol (2025)	Both Drugs and Alcohol (2024)	Both Drugs and Alcohol (2025)	Substance Use Disorder (2024)	Substance Use Disorder (2025)
TOTAL¹	92.2	92.6	6.6	5.9	4.7	4.4	1.0	0.8	3.0	2.8	1.8	1.4	7.8	7.4
MDE^2,3	79.4^a	83.7	18.1^a	14.4	13.3	10.2	2.8	1.7	8.5^a	5.9	6.0	4.0	20.6^a	16.3
Age Group
12‑13	91.0	89.7	8.1	8.9	4.0	2.8	3.5	2.2	3.9	3.6	3.0	*	9.0	10.3
14‑15	84.1	84.5	14.5	14.1	9.9	11.1	2.4	1.0	5.7	5.3	4.2	3.9	15.9	15.5
16‑17	70.4^b	80.2	25.6^b	17.2	20.3^a	12.8	2.7	2.1	12.9^a	7.4	8.8^a	4.8	29.6^b	19.8
Sex
Male	77.1	82.8	20.1	14.8	14.3	10.4	2.6	1.1	7.0	4.5	4.3	2.1	22.9	17.2
Female	80.2	84.1	17.4	14.2	12.9	10.1	2.9	1.9	9.1	6.4	6.7	4.7	19.8	15.9
MDE with Severe Impairment^4,5	77.7^a	82.8	19.7^a	15.1	14.4	10.7	3.3	2.0	9.4^a	6.2	6.7^a	4.1	22.3^a	17.2
Age Group
12‑13	89.3	88.5	9.8	9.4	4.8	3.8	4.2	2.1	4.9	*	4.0	1.0	10.7	11.5
14‑15	84.2	83.6	14.5	15.1	9.3	11.8	3.2	1.2	6.0	6.1	4.7	4.9	15.8	16.4
16‑17	67.4^b	79.7	28.2^b	17.6	22.8^b	12.8	3.0	2.6	14.0^a	7.5	9.6^a	4.8	32.6^b	20.3
Sex
Male	72.3^a	83.8	24.6^a	13.2	17.3^a	9.2	3.6	0.9	8.3	5.5	5.2	2.5	27.7^a	16.2
Female	79.6	82.4	17.9	15.9	13.4	11.4	3.2	2.4	9.7	6.5	7.3	4.8	20.4	17.6
NO MDE^2,3	94.6	94.4	4.4	4.3	3.1	3.3	0.7	0.5	1.9	2.2	0.9	0.9	5.4	5.6
Age Group
12‑13	98.0	97.8	1.7	1.8	0.4	0.9	0.6	0.4	0.4	0.6	0.1	0.2	2.0	2.2
14‑15	95.7	95.1	3.5	3.9	2.2	2.8	0.7	0.5	1.7	1.5	0.9	0.5	4.3	4.9
16‑17	90.2	90.3	7.9	7.2	6.6	6.1	0.8	0.6	3.8	4.4	1.8	1.9	9.8	9.7
Sex
Male	95.1	94.1	4.2	4.7	3.0	3.6	0.4	0.7	1.4	2.2	0.7	1.0	4.9	5.9
Female	94.0	94.8	4.6	3.8	3.2	2.9	1.1^b	0.3	2.6	2.1	1.2	0.7	6.0	5.2
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown past year MDE data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.31A – Substance Use Disorder or Major Depressive Episode (MDE) and Substance Use Disorder or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	Substance Use Disorder or MDE^1,2 (2024)	Substance Use Disorder or MDE^1,2 (2025)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2024)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2025)
TOTAL	5,071	4,979	4,226	4,127
AGE GROUP
12‑13	937	893	745	679
14‑15	1,699	1,778	1,392	1,461
16‑17	2,435	2,308	2,089	1,987
SEX
Male	1,694	1,822	1,391	1,579
Female	3,377	3,157	2,835	2,549
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,713	3,548	3,074	2,941
AIAN	27	44	23	36
Asian	208	174	172	113
Black or African American	579	603	499	516
NHPI	2	*	2	*
White	2,592	2,398	2,130	2,004
Two or More Races	305	318	247	260
Hispanic or Latino	1,358	1,431	1,152	1,186
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.31B – Substance Use Disorder or Major Depressive Episode (MDE) and Substance Use Disorder or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	Substance Use Disorder or MDE^1,2 (2024)	Substance Use Disorder or MDE^1,2 (2025)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2024)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2025)
TOTAL	20.2	20.1	16.8	16.7
AGE GROUP
12‑13	12.2	11.9	9.7	9.0
14‑15	19.8	20.9	16.3	17.1
16‑17	27.4	26.6	23.5	22.9
SEX
Male	13.2	14.5	10.8	12.5
Female	27.6	26.1	23.2	21.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	20.1	19.6	16.7	16.2
AIAN	13.6	16.7	11.6	13.9
Asian	14.4	11.8	11.9	7.7
Black or African American	16.7	18.1	14.4	15.4
NHPI	3.4	*	3.0	*
White	21.1	20.5	17.4	17.1
Two or More Races	30.2	24.7	24.6	20.2
Hispanic or Latino	20.5	21.7	17.4	18.0
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.32A – Substance Use Disorder or Major Depressive Episode (MDE) and Substance Use Disorder or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	Substance Use Disorder or MDE^1,2 (2024)	Substance Use Disorder or MDE^1,2 (2025)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2024)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2025)
TOTAL	5,071	4,979	4,226	4,127
GEOGRAPHIC DIVISION
Northeast	733	753	628	633
New England	194	159	165	132
Middle Atlantic	539	594	463	501
Midwest	1,013	1,047	816	880
East North Central	660	704	536	594
West North Central	353	343	280	286
South	1,997	2,011	1,673	1,658
South Atlantic	896	1,022	773	830
East South Central	334	346	298	263
West South Central	767	644	603	565
West	1,328	1,168	1,109	957
Mountain	500	442	414	369
Pacific	828	726	695	588
COUNTY TYPE
Large Metro	2,696	2,764	2,287	2,294
Small Metro	1,823	1,662	1,490	1,391
Nonmetro	553	552	449	442
Urbanized	187	196	160	160
Less Urbanized	183	230	144	184
Completely Rural	182	126	144	98
POVERTY LEVEL
Less Than 100%	1,039	1,119	859	977
100‑199%	1,077	1,155	942	950
200% or More	2,955	2,706	2,425	2,200
HEALTH INSURANCE⁵
Private	2,823	2,664	2,329	2,148
Medicaid/CHIP	2,154	2,198	1,824	1,886
Other⁶	212^b	348	171^b	283
No Coverage	236	172	205	147
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. ⁵ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁶ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.32B – Substance Use Disorder or Major Depressive Episode (MDE) and Substance Use Disorder or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	Substance Use Disorder or MDE^1,2 (2024)	Substance Use Disorder or MDE^1,2 (2025)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2024)	Substance Use Disorder or MDE with Severe Impairment^1,3,4 (2025)
TOTAL	20.2	20.1	16.8	16.7
GEOGRAPHIC DIVISION
Northeast	18.7	19.2	16.1	16.1
New England	19.3	16.0	16.4	13.2
Middle Atlantic	18.5	20.2	15.9	17.1
Midwest	19.5	20.4	15.7	17.2
East North Central	18.8	20.5	15.3	17.3
West North Central	20.8	20.3	16.5	16.9
South	19.9	20.4	16.7	16.8
South Atlantic	18.0	20.8	15.5	16.9
East South Central	22.0	23.6	19.6	17.9
West South Central	21.6	18.5	17.0	16.3
West	22.4	20.1	18.7	16.5
Mountain	25.2	22.1	20.9	18.5
Pacific	21.0	19.0	17.6	15.4
COUNTY TYPE
Large Metro	18.6	19.6	15.8	16.3
Small Metro	23.1	20.9	18.9	17.5
Nonmetro	20.2	20.5	16.4	16.5
Urbanized	18.3	20.2	15.7	16.6
Less Urbanized	18.3	20.2	14.4	16.1
Completely Rural	25.6	21.7	20.3	16.9
POVERTY LEVEL
Less Than 100%	19.5	20.5	16.1	17.9
100‑199%	21.0	20.9	18.3	17.2
200% or More	20.2	19.7	16.6	16.0
HEALTH INSURANCE⁵
Private	19.9	19.7	16.4	15.8
Medicaid/CHIP	21.3	21.7	18.1	18.6
Other⁶	15.7^b	25.5	12.7^b	20.7
No Coverage	20.4	15.8	17.7	13.5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Respondents with unknown past year major depressive episode (MDE) data were excluded. ³ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁴ Respondents with unknown MDE data or unknown impairment data were excluded. ⁵ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁶ Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.33A – Co‑Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Sex, Numbers in Thousands, 2024 and 2025
Co‑Occurring Substance Use Disorder and MDE	Total (2024)	Total (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
Substance Use Disorder and MDE	792^a	604	247	188	545^a	415
Substance Use Disorder and MDE with Severe Impairment^1,2	632^a	467	204	128	428	339
Drug Use Disorder and MDE	696^a	533	217	162	479	371
Drug Use Disorder and MDE with Severe Impairment^1,2	557^a	411	181	104	376	307
Alcohol Use Disorder and MDE	328^a	218	76	49	251	168
Alcohol Use Disorder and MDE with Severe Impairment^1,2	265^a	168	61	43	204^a	125
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.33B – Co‑Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Sex, Percentages, 2024 and 2025
Co‑Occurring Substance Use Disorder and MDE	Total (2024)	Total (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
Substance Use Disorder and MDE	3.2^a	2.5	1.9	1.5	4.5^a	3.4
Substance Use Disorder and MDE with Severe Impairment^1,2	2.5^a	1.9	1.6	1.0	3.5	2.8
Drug Use Disorder and MDE	2.8^a	2.2	1.7	1.3	3.9	3.1
Drug Use Disorder and MDE with Severe Impairment^1,2	2.2^a	1.7	1.4	0.8	3.1	2.5
Alcohol Use Disorder and MDE	1.3^a	0.9	0.6	0.4	2.1	1.4
Alcohol Use Disorder and MDE with Severe Impairment^1,2	1.1^a	0.7	0.5	0.3	1.7^a	1.0
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.34A – Substance Use Disorder (SUD) Severity Level for Specific Substances in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment, Numbers in Thousands, 2024 and 2025
Substance Use Disorder Severity Level	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	25,952	25,455	3,840	3,706	2,834	2,717	21,161	20,910
Substance Use Disorder	2,024	1,877	792^a	604	632^a	467	1,141	1,176
Mild SUD	992	928	329^a	223	252	173	613	648
Moderate SUD	496	479	197	173	157	116	274	287
Severe SUD	535	470	267	207	222	177	254	241
No SUD	23,928	23,578	3,047	3,102	2,202	2,250	20,020	19,734
Drug Use Disorder	1,705	1,511	696^a	533	557^a	411	928	905
Mild SUD	830	702	284^a	183	221	144	502	480
Moderate SUD	420	384	185	159	147	102	212	208
Severe SUD	455	425	227	191	189	164	215	217
No SUD	24,247	23,944	3,144	3,172	2,277	2,306	20,232	20,005
Marijuana Use Disorder	1,219	1,118	511^a	377	409	292	656	687
Mild SUD	437	399	151	89	118	74	266	289
Moderate SUD	368	346	146	131	113	84	203	198
Severe SUD	414	373	215	157	179	134	186	199
No SUD	24,732	24,337	3,328	3,329	2,425	2,425	20,505	20,224
Opioid Use Disorder	267	207	107	62	94	54	150	108
Mild SUD	210	161	75	40	69	32	126	93
Moderate SUD	28	11	20	5	15	5	8	5
Severe SUD	28	35	11	17	9	16	17	9
No SUD	25,685	25,247	3,733	3,644	2,740	2,663	21,011	20,803
Alcohol Use Disorder	775	710	328^a	218	265^a	168	411	452
Mild SUD	406	423	172	128	131	89	222	274
Moderate SUD	220	185	84	50	72	46	119	120
Severe SUD	149	103	72	39	63	32	70	58
No SUD	25,176	24,745	3,512	3,488	2,569	2,549	20,750	20,459
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.34B – Substance Use Disorder (SUD) Severity Level for Specific Substances in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment, Percentages, 2024 and 2025
Substance Use Disorder Severity Level	Aged 12‑17¹ (2024)	Aged 12‑17¹ (2025)	Had MDE^2,3 (2024)	Had MDE^2,3 (2025)	Had MDE with Severe Impairment^2,4,5 (2024)	Had MDE with Severe Impairment^2,4,5 (2025)	No MDE^2,3 (2024)	No MDE^2,3 (2025)
TOTAL	100.0	100.0	100.0	100.0	100.0	100.0	100.0	100.0
Substance Use Disorder	7.8	7.4	20.6^a	16.3	22.3^a	17.2	5.4	5.6
Mild SUD	3.8	3.6	8.6^a	6.0	8.9	6.4	2.9	3.1
Moderate SUD	1.9	1.9	5.1	4.7	5.6	4.3	1.3	1.4
Severe SUD	2.1	1.8	7.0	5.6	7.8	6.5	1.2	1.2
No SUD	92.2	92.6	79.4^a	83.7	77.7^a	82.8	94.6	94.4
Drug Use Disorder	6.6	5.9	18.1^a	14.4	19.7^a	15.1	4.4	4.3
Mild SUD	3.2	2.8	7.4^a	4.9	7.8	5.3	2.4	2.3
Moderate SUD	1.6	1.5	4.8	4.3	5.2	3.8	1.0	1.0
Severe SUD	1.8	1.7	5.9	5.1	6.7	6.1	1.0	1.0
No SUD	93.4	94.1	81.9^a	85.6	80.3^a	84.9	95.6	95.7
Marijuana Use Disorder	4.7	4.4	13.3	10.2	14.4	10.7	3.1	3.3
Mild SUD	1.7	1.6	3.9	2.4	4.2	2.7	1.3	1.4
Moderate SUD	1.4	1.4	3.8	3.5	4.0	3.1	1.0	0.9
Severe SUD	1.6	1.5	5.6	4.2	6.3	4.9	0.9	1.0
No SUD	95.3	95.6	86.7	89.8	85.6	89.3	96.9	96.7
Opioid Use Disorder	1.0	0.8	2.8	1.7	3.3	2.0	0.7	0.5
Mild SUD	0.8	0.6	2.0	1.1	2.4	1.2	0.6	0.4
Moderate SUD	0.1	<0.1	0.5	0.1	0.5	0.2	<0.1	<0.1
Severe SUD	0.1	0.1	0.3	0.4	0.3	0.6	0.1	<0.1
No SUD	99.0	99.2	97.2	98.3	96.7	98.0	99.3	99.5
Alcohol Use Disorder	3.0	2.8	8.5^a	5.9	9.4^a	6.2	1.9	2.2
Mild SUD	1.6	1.7	4.5	3.5	4.6	3.3	1.1	1.3
Moderate SUD	0.8	0.7	2.2	1.4	2.5	1.7	0.6	0.6
Severe SUD	0.6	0.4	1.9	1.1	2.2	1.2	0.3	0.3
No SUD	97.0	97.2	91.5^a	94.1	90.6^a	93.8	98.1	97.8
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes respondents with unknown MDE data and respondents with unknown MDE with severe impairment data. ² Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ³ Respondents with unknown past year major depressive episode (MDE) data were excluded. ⁴ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ⁵ Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.35A – Received Substance Use Treatment and/or Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment and Age Group, Numbers in Thousands, 2024 and 2025
Substance Use Disorder/MDE/Age Group	Received Substance Use Treatment (SU Tx) OR Mental Health Treatment (MH Tx) (2024)	Received Substance Use Treatment (SU Tx) OR Mental Health Treatment (MH Tx) (2025)	Received SU Tx BUT NOT MH Tx (2024)	Received SU Tx BUT NOT MH Tx (2025)	Received MH Tx BUT NOT SU Tx (2024)	Received MH Tx BUT NOT SU Tx (2025)	Received SU Tx AND MH Tx (2024)	Received SU Tx AND MH Tx (2025)	Received NEITHER SU Tx NOR MH Tx (2024)	Received NEITHER SU Tx NOR MH Tx (2025)
Substance Use Disorder and MDE	‑‑	455	‑‑	5	‑‑	364	‑‑	86	‑‑	148
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
16‑17	‑‑	238	‑‑	*	‑‑	199	‑‑	38	‑‑	74
Substance Use Disorder and MDE with Severe Impairment^1,2	‑‑	376	‑‑	5	‑‑	302	‑‑	68	‑‑	91
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
16‑17	‑‑	195	‑‑	*	‑‑	165	‑‑	29	‑‑	45
Substance Use Disorder and No MDE	‑‑	520	‑‑	45	‑‑	330	‑‑	146	‑‑	656
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	*	‑‑	15	‑‑	100	‑‑	*	‑‑	*
16‑17	‑‑	298	‑‑	28	‑‑	186	‑‑	83	‑‑	385
MDE and No Substance Use Disorder	‑‑	1,690	‑‑	4	‑‑	1,650	‑‑	37	‑‑	1,412
12‑13	‑‑	384	‑‑	1	‑‑	383	‑‑	*	‑‑	275
14‑15	‑‑	690	‑‑	*	‑‑	673	‑‑	17	‑‑	487
16‑17	‑‑	616	‑‑	2	‑‑	594	‑‑	20	‑‑	650
No Substance Use Disorder and No MDE	‑‑	4,091	‑‑	67	‑‑	3,950	‑‑	75	‑‑	15,643
12‑13	‑‑	1,420	‑‑	12	‑‑	1,379	‑‑	29	‑‑	5,202
14‑15	‑‑	1,459	‑‑	26	‑‑	1,413	‑‑	20	‑‑	5,280
16‑17	‑‑	1,213	‑‑	29	‑‑	1,158	‑‑	26	‑‑	5,161
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.35B – Received Substance Use Treatment and/or Mental Health Treatment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment and Age Group, Percentages, 2024 and 2025
Substance Use Disorder/MDE/Age Group	Received Substance Use Treatment (SU Tx) OR Mental Health Treatment (MH Tx) (2024)	Received Substance Use Treatment (SU Tx) OR Mental Health Treatment (MH Tx) (2025)	Received SU Tx BUT NOT MH Tx (2024)	Received SU Tx BUT NOT MH Tx (2025)	Received MH Tx BUT NOT SU Tx (2024)	Received MH Tx BUT NOT SU Tx (2025)	Received SU Tx AND MH Tx (2024)	Received SU Tx AND MH Tx (2025)	Received NEITHER SU Tx NOR MH Tx (2024)	Received NEITHER SU Tx NOR MH Tx (2025)
Substance Use Disorder and MDE	‑‑	75.4	‑‑	0.9	‑‑	60.2	‑‑	14.3	‑‑	24.6
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
16‑17	‑‑	76.2	‑‑	*	‑‑	63.8	‑‑	12.1	‑‑	23.8
Substance Use Disorder and MDE with Severe Impairment^1,2	‑‑	80.6	‑‑	1.2	‑‑	64.7	‑‑	14.7	‑‑	19.4
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
16‑17	‑‑	81.1	‑‑	*	‑‑	68.5	‑‑	12.2	‑‑	18.9
Substance Use Disorder and No MDE	‑‑	44.3	‑‑	3.8	‑‑	28.1	‑‑	12.4	‑‑	55.7
12‑13	‑‑	*	‑‑	*	‑‑	*	‑‑	*	‑‑	*
14‑15	‑‑	*	‑‑	4.2	‑‑	28.8	‑‑	*	‑‑	*
16‑17	‑‑	43.6	‑‑	4.1	‑‑	27.3	‑‑	12.2	‑‑	56.4
MDE and No Substance Use Disorder	‑‑	54.5	‑‑	0.1	‑‑	53.2	‑‑	1.2	‑‑	45.5
12‑13	‑‑	58.3	‑‑	0.2	‑‑	58.1	‑‑	*	‑‑	41.7
14‑15	‑‑	58.6	‑‑	*	‑‑	57.2	‑‑	1.5	‑‑	41.4
16‑17	‑‑	48.7	‑‑	0.2	‑‑	46.9	‑‑	1.6	‑‑	51.3
No Substance Use Disorder and No MDE	‑‑	20.7	‑‑	0.3	‑‑	20.0	‑‑	0.4	‑‑	79.3
12‑13	‑‑	21.4	‑‑	0.2	‑‑	20.8	‑‑	0.4	‑‑	78.6
14‑15	‑‑	21.6	‑‑	0.4	‑‑	21.0	‑‑	0.3	‑‑	78.4
16‑17	‑‑	19.0	‑‑	0.5	‑‑	18.2	‑‑	0.4	‑‑	81.0
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. NOTE: Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.36A – Engaged in Nonsuicidal Self‑Harm in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	ENGAGED IN NONSUICIDAL SELF‑HARM
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	‑‑	2,844	‑‑	20,351	‑‑	735	‑‑	1,428
AGE GROUP
12‑13	‑‑	720	‑‑	6,349	‑‑	243	‑‑	510
14‑15	‑‑	1,162	‑‑	6,768	‑‑	250	‑‑	495
16‑17	‑‑	963	‑‑	7,234	‑‑	242	‑‑	422
SEX
Male	‑‑	755	‑‑	11,363	‑‑	300	‑‑	538
Female	‑‑	2,089	‑‑	8,988	‑‑	435	‑‑	890
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	2,157	‑‑	14,882	‑‑	502	‑‑	1,027
AIAN	‑‑	21	‑‑	211	‑‑	12	‑‑	25
Asian	‑‑	125	‑‑	1,270	‑‑	46	‑‑	89
Black or African American	‑‑	267	‑‑	2,827	‑‑	94	‑‑	196
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	1,560	‑‑	9,478	‑‑	303	‑‑	642
Two or More Races	‑‑	179	‑‑	1,047	‑‑	45	‑‑	61
Hispanic or Latino	‑‑	687	‑‑	5,470	‑‑	233	‑‑	401
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth nonsuicidal self‑harm measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown nonsuicidal self‑harm data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.36B – Engaged in Nonsuicidal Self‑Harm in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	ENGAGED IN NONSUICIDAL SELF‑HARM
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	‑‑	11.2	‑‑	80.3	‑‑	2.9	‑‑	5.6
AGE GROUP
12‑13	‑‑	9.2	‑‑	81.2	‑‑	3.1	‑‑	6.5
14‑15	‑‑	13.4	‑‑	78.0	‑‑	2.9	‑‑	5.7
16‑17	‑‑	10.9	‑‑	81.6	‑‑	2.7	‑‑	4.8
SEX
Male	‑‑	5.8	‑‑	87.7	‑‑	2.3	‑‑	4.2
Female	‑‑	16.8	‑‑	72.5	‑‑	3.5	‑‑	7.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	‑‑	11.6	‑‑	80.2	‑‑	2.7	‑‑	5.5
AIAN	‑‑	7.9	‑‑	78.6	‑‑	4.4	‑‑	9.1
Asian	‑‑	8.2	‑‑	83.0	‑‑	3.0	‑‑	5.8
Black or African American	‑‑	7.9	‑‑	83.5	‑‑	2.8	‑‑	5.8
NHPI	‑‑	*	‑‑	*	‑‑	*	‑‑	*
White	‑‑	13.0	‑‑	79.1	‑‑	2.5	‑‑	5.4
Two or More Races	‑‑	13.4	‑‑	78.6	‑‑	3.4	‑‑	4.6
Hispanic or Latino	‑‑	10.1	‑‑	80.5	‑‑	3.4	‑‑	5.9
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth nonsuicidal self‑harm measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown nonsuicidal self‑harm data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.37A – Engaged in Nonsuicidal Self‑Harm in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	ENGAGED IN NONSUICIDAL SELF‑HARM
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	‑‑	2,844	‑‑	20,351	‑‑	735	‑‑	1,428
GEOGRAPHIC DIVISION
Northeast	‑‑	425	‑‑	3,175	‑‑	119	‑‑	257
New England	‑‑	96	‑‑	817	‑‑	18	‑‑	76
Middle Atlantic	‑‑	329	‑‑	2,358	‑‑	101	‑‑	182
Midwest	‑‑	648	‑‑	4,250	‑‑	136	‑‑	248
East North Central	‑‑	434	‑‑	2,847	‑‑	100	‑‑	176
West North Central	‑‑	214	‑‑	1,403	‑‑	36	‑‑	72
South	‑‑	1,089	‑‑	8,106	‑‑	283	‑‑	627
South Atlantic	‑‑	586	‑‑	3,954	‑‑	166	‑‑	318
East South Central	‑‑	163	‑‑	1,196	‑‑	42	‑‑	113
West South Central	‑‑	339	‑‑	2,957	‑‑	75	‑‑	196
West	‑‑	683	‑‑	4,820	‑‑	197	‑‑	295
Mountain	‑‑	213	‑‑	1,675	‑‑	51	‑‑	106
Pacific	‑‑	469	‑‑	3,144	‑‑	146	‑‑	189
COUNTY TYPE
Large Metro	‑‑	1,489	‑‑	11,786	‑‑	366	‑‑	827
Small Metro	‑‑	986	‑‑	6,446	‑‑	309	‑‑	427
Nonmetro	‑‑	370	‑‑	2,119	‑‑	60	‑‑	174
Urbanized	‑‑	124	‑‑	761	‑‑	33	‑‑	62
Less Urbanized	‑‑	166	‑‑	914	‑‑	14	‑‑	58
Completely Rural	‑‑	80	‑‑	444	‑‑	13	‑‑	54
POVERTY LEVEL
Less Than 100%	‑‑	582	‑‑	4,432	‑‑	195	‑‑	420
100‑199%	‑‑	607	‑‑	4,548	‑‑	173	‑‑	360
200% or More	‑‑	1,655	‑‑	11,371	‑‑	367	‑‑	648
HEALTH INSURANCE¹
Private	‑‑	1,601	‑‑	11,144	‑‑	357	‑‑	722
Medicaid/CHIP	‑‑	1,131	‑‑	8,328	‑‑	360	‑‑	621
Other²	‑‑	240	‑‑	1,107	‑‑	60	‑‑	42
No Coverage	‑‑	111	‑‑	897	‑‑	20	‑‑	95
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth nonsuicidal self‑harm measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown nonsuicidal self‑harm data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.37B – Engaged in Nonsuicidal Self‑Harm in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	ENGAGED IN NONSUICIDAL SELF‑HARM
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	‑‑	11.2	‑‑	80.3	‑‑	2.9	‑‑	5.6
GEOGRAPHIC DIVISION
Northeast	‑‑	10.7	‑‑	79.8	‑‑	3.0	‑‑	6.5
New England	‑‑	9.6	‑‑	81.1	‑‑	1.8	‑‑	7.5
Middle Atlantic	‑‑	11.1	‑‑	79.4	‑‑	3.4	‑‑	6.1
Midwest	‑‑	12.3	‑‑	80.5	‑‑	2.6	‑‑	4.7
East North Central	‑‑	12.2	‑‑	80.0	‑‑	2.8	‑‑	5.0
West North Central	‑‑	12.4	‑‑	81.3	‑‑	2.1	‑‑	4.1
South	‑‑	10.8	‑‑	80.2	‑‑	2.8	‑‑	6.2
South Atlantic	‑‑	11.7	‑‑	78.7	‑‑	3.3	‑‑	6.3
East South Central	‑‑	10.8	‑‑	79.0	‑‑	2.8	‑‑	7.4
West South Central	‑‑	9.5	‑‑	82.9	‑‑	2.1	‑‑	5.5
West	‑‑	11.4	‑‑	80.4	‑‑	3.3	‑‑	4.9
Mountain	‑‑	10.4	‑‑	81.9	‑‑	2.5	‑‑	5.2
Pacific	‑‑	11.9	‑‑	79.6	‑‑	3.7	‑‑	4.8
COUNTY TYPE
Large Metro	‑‑	10.3	‑‑	81.5	‑‑	2.5	‑‑	5.7
Small Metro	‑‑	12.1	‑‑	78.9	‑‑	3.8	‑‑	5.2
Nonmetro	‑‑	13.6	‑‑	77.8	‑‑	2.2	‑‑	6.4
Urbanized	‑‑	12.6	‑‑	77.6	‑‑	3.4	‑‑	6.3
Less Urbanized	‑‑	14.4	‑‑	79.4	‑‑	1.2	‑‑	5.1
Completely Rural	‑‑	13.6	‑‑	75.2	‑‑	2.1	‑‑	9.1
POVERTY LEVEL
Less Than 100%	‑‑	10.3	‑‑	78.7	‑‑	3.5	‑‑	7.5
100‑199%	‑‑	10.7	‑‑	80.0	‑‑	3.0	‑‑	6.3
200% or More	‑‑	11.8	‑‑	81.0	‑‑	2.6	‑‑	4.6
HEALTH INSURANCE¹
Private	‑‑	11.6	‑‑	80.6	‑‑	2.6	‑‑	5.2
Medicaid/CHIP	‑‑	10.8	‑‑	79.8	‑‑	3.4	‑‑	5.9
Other²	‑‑	16.6	‑‑	76.4	‑‑	4.1	‑‑	2.9
No Coverage	‑‑	9.9	‑‑	79.8	‑‑	1.8	‑‑	8.5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth nonsuicidal self‑harm measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown nonsuicidal self‑harm data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.38A – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	2,613	2,625	19,794	19,235	1,740	1,825	1,754	1,672
AGE GROUP
12‑13	661	668	6,229	5,983	540	542	651	629
14‑15	917	988	6,731	6,478	612	661	587	548
16‑17	1,035	969	6,834	6,775	588	622	516	495
SEX
Male	831	799	11,056	10,695	665	718	687	744
Female	1,782	1,827	8,738	8,540	1,074	1,108	1,067	928
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,972	1,993	14,478	14,022	1,242	1,338	1,321	1,214
AIAN	16	23	155	207	13	17	*	22
Asian	141	119	1,175	1,182	105	80	93	149
Black or African American	314	338	2,687	2,539	224	257	331	251
NHPI	*	*	*	*	*	*	*	*
White	1,347	1,324	9,701	9,062	807	875	758	722
Two or More Races	146	184	694^b	988	90	102	111^a	58
Hispanic or Latino	641	632	5,316	5,213	498	487	433	459
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.38B – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	10.1	10.4	76.4	75.9	6.7	7.2	6.8	6.6
AGE GROUP
12‑13	8.2	8.5	77.1	76.5	6.7	6.9	8.1	8.0
14‑15	10.4	11.4	76.1	74.7	6.9	7.6	6.6	6.3
16‑17	11.5	10.9	76.2	76.5	6.6	7.0	5.8	5.6
SEX
Male	6.3	6.2	83.5	82.6	5.0	5.5	5.2	5.7
Female	14.1	14.7	69.0	68.9	8.5	8.9	8.4	7.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10.4	10.7	76.1	75.5	6.5	7.2	6.9	6.5
AIAN	7.6	8.6	74.3	76.9	6.3	6.3	*	8.2
Asian	9.3	7.8	77.6	77.2	6.9	5.2	6.2	9.8
Black or African American	8.8	10.0	75.6	75.0	6.3	7.6	9.3	7.4
NHPI	*	*	*	*	*	*	*	*
White	10.7	11.0	76.9	75.6	6.4	7.3	6.0	6.0
Two or More Races	14.0	13.8	66.7^a	74.2	8.6	7.6	10.6^b	4.4
Hispanic or Latino	9.3	9.3	77.2	76.8	7.2	7.2	6.3	6.8
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.39A – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	MADE ANY SUICIDE PLANS
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	1,186	1,288	22,580	21,878	668	762	1,466	1,430
AGE GROUP
12‑13	327	353	6,995	6,692	198	245	560	532
14‑15	385	466	7,683	7,455	295	269	484	485
16‑17	474	469	7,902	7,732	176	247	422	412
SEX
Male	356	376	12,051	11,667	263	286	570	627
Female	830	912	10,529	10,211	405	476	896	803
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	923	1,003	16,550	16,007	444	524	1,096	1,034
AIAN	12	11	163^a	229	7	6	*	23
Asian	56	50	1,363	1,331	19	43	76	107
Black or African American	175	156	3,009	2,889	84	134	289	206
NHPI	<1	*	79	*	*	*	1	*
White	601	688	11,093	10,363	294	293	624	639
Two or More Races	78	97	843^b	1,142	40	46	79	48
Hispanic or Latino	264	286	6,030	5,871	224	238	370	396
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.39B – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	MADE ANY SUICIDE PLANS
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	4.6	5.1	87.2	86.3	2.6	3.0	5.7	5.6
AGE GROUP
12‑13	4.0	4.5	86.6	85.6	2.4	3.1	6.9	6.8
14‑15	4.4	5.4	86.8	85.9	3.3	3.1	5.5	5.6
16‑17	5.3	5.3	88.1	87.3	2.0	2.8	4.7	4.7
SEX
Male	2.7	2.9	91.0	90.1	2.0	2.2	4.3	4.8
Female	6.6	7.4	83.2	82.3	3.2	3.8	7.1	6.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4.9	5.4	87.0	86.2	2.3	2.8	5.8	5.6
AIAN	5.8	4.1	78.0	85.2	3.3	2.4	*	8.4
Asian	3.7	3.2	90.0	87.0	1.2	2.8	5.0	7.0
Black or African American	4.9	4.6	84.6	85.3	2.4	3.9	8.1	6.1
NHPI	<0.1	*	96.7	*	*	*	1.6	*
White	4.8	5.7	88.0	86.5	2.3	2.4	4.9	5.3
Two or More Races	7.5	7.3	81.0	85.7	3.8	3.4	7.6^b	3.6
Hispanic or Latino	3.8	4.2	87.5	86.5	3.3	3.5	5.4	5.8
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.40A – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	ATTEMPTED SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	700	738	23,524	22,896	431	463	1,246	1,261
AGE GROUP
12‑13	210	225	7,241	6,959	136	166	493	472
14‑15	219	279	8,085	7,814	174	126	369	455
16‑17	271	233	8,198	8,123	121	171	384	334
SEX
Male	220	178	12,327	12,063	198	171	495	543
Female	480	560	11,197	10,833	233	292	751	718
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	529	591	17,200	16,764	301	289	983	924
AIAN	9	10	167^a	237	4	5	*	17
Asian	27	15	1,407	1,399	23	11	57	104
Black or African American	121	92	3,106	3,051	73	81	256^a	161
NHPI	*	*	*	*	*	*	*	*
White	333	428	11,524	10,810	169	163	587	582
Two or More Races	38	45	917^b	1,213	32	27	54	47
Hispanic or Latino	171	147	6,324	6,132	130	174	263	337
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.40B – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	ATTEMPTED SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	2.7	2.9	90.8	90.3	1.7	1.8	4.8	5.0
AGE GROUP
12‑13	2.6	2.9	89.6	89.0	1.7	2.1	6.1	6.0
14‑15	2.5	3.2	91.4	90.1	2.0	1.5	4.2	5.2
16‑17	3.0	2.6	91.4	91.7	1.3	1.9	4.3	3.8
SEX
Male	1.7	1.4	93.1	93.1	1.5	1.3	3.7	4.2
Female	3.8	4.5	88.4	87.3	1.8	2.4	5.9	5.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.8	3.2	90.5	90.3	1.6	1.6	5.2	5.0
AIAN	4.4	3.6	80.3	88.0	1.8	2.0	*	6.4
Asian	1.8	1.0	92.9	91.4	1.5	0.7	3.8	6.8
Black or African American	3.4	2.7	87.4	90.1	2.0	2.4	7.2^a	4.8
NHPI	*	*	*	*	*	*	*	*
White	2.6	3.6	91.4	90.2	1.3	1.4	4.7	4.9
Two or More Races	3.7	3.4	88.1	91.0	3.0	2.0	5.2	3.5
Hispanic or Latino	2.5	2.2	91.8	90.3	1.9	2.6	3.8	5.0
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.41A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2024 and 2025
Demographic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY SUICIDE PLANS, OR ATTEMPTED SUICIDE
	Any of These Suicidality Measures		None of These Suicidality Measures		Unknown
	2024	2025	2024	2025	2024	2025
TOTAL	2,800	2,772	19,593	19,012	3,508	3,574
AGE GROUP
12‑13	714	703	6,152	5,919	1,215	1,200
14‑15	976	1,057	6,680	6,410	1,191	1,209
16‑17	1,110	1,013	6,761	6,683	1,102	1,165
SEX
Male	893	865	10,937	10,597	1,409	1,493
Female	1,907	1,907	8,656	8,415	2,099	2,081
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,107	2,100	14,314	13,854	2,592	2,613
AIAN	18	24	149	204	41	41
Asian	153	132	1,172	1,162	188	236
Black or African American	345	363	2,645	2,492	567	529
NHPI	*	*	*	*	*	*
White	1,421	1,380	9,606	8,974	1,585	1,630
Two or More Races	161	194	675^b	978	205	159
Hispanic or Latino	693	673	5,279	5,158	916	961
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The “any of these suicidality measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “none of these suicidality measures” category includes respondents with “no” responses to all three measures. The “unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.41B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2024 and 2025
Demographic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY SUICIDE PLANS, OR ATTEMPTED SUICIDE
	Any of These Suicidality Measures		None of These Suicidality Measures		Unknown
	2024	2025	2024	2025	2024	2025
TOTAL	10.8	10.9	75.6	75.0	13.5	14.1
AGE GROUP
12‑13	8.8	9.0	76.1	75.7	15.0	15.3
14‑15	11.0	12.2	75.5	73.9	13.5	13.9
16‑17	12.4	11.4	75.3	75.4	12.3	13.1
SEX
Male	6.7	6.7	82.6	81.8	10.6	11.5
Female	15.1	15.4	68.4	67.8	16.6	16.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	11.1	11.3	75.3	74.6	13.6	14.1
AIAN	8.5	8.9	71.7	75.9	19.7	15.2
Asian	10.1	8.6	77.5	76.0	12.4	15.4
Black or African American	9.7	10.7	74.4	73.6	15.9	15.6
NHPI	*	*	*	*	*	*
White	11.3	11.5	76.2	74.9	12.6	13.6
Two or More Races	15.5	14.6	64.9^a	73.5	19.7^b	12.0
Hispanic or Latino	10.1	9.9	76.6	75.9	13.3	14.1
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: The “any of these suicidality measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “none of these suicidality measures” category includes respondents with “no” responses to all three measures. The “unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.42A – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	2,613	2,625	19,794	19,235	1,740	1,825	1,754	1,672
GEOGRAPHIC DIVISION
Northeast	430	407	3,069	3,017	279	295	296	258
New England	105	95	796	791	58	39	82	82
Middle Atlantic	324	312	2,273	2,225	221	256	214	176
Midwest	500	543	4,182	3,987	404	422	316	330
East North Central	298	361	2,825	2,704	295	264	226	227
West North Central	201	182	1,357	1,283	109	158	91	103
South	1,009	978	7,925	7,715	651	631	711	781
South Atlantic	488	503	3,999	3,751	284	369	348	401
East South Central	164	193	1,132	1,110	125	68	119	143
West South Central	357	282	2,794	2,853	243	194	244	237
West	675	696	4,617	4,517	405	478	431^a	303
Mountain	272	261	1,467	1,548	147	144	169^a	93
Pacific	403	436	3,150	2,969	258	333	261	211
COUNTY TYPE
Large Metro	1,411	1,438	11,468	11,101	1,043	1,060	1,114^a	868
Small Metro	889	881	6,137	6,081	573	587	481	619
Nonmetro	313	306	2,189	2,053	124	178	159	186
Urbanized	115	109	823	728	50	80	48	64
Less Urbanized	100	133	823	883	45	60	59	76
Completely Rural	98	65	544	442	28	38	52	46
POVERTY LEVEL
Less Than 100%	482	585	4,195	4,172	277	391	543	481
100‑199%	493	598	4,082	4,315	379	372	350	404
200% or More	1,638	1,442	11,516	10,749	1,083	1,063	860	788
HEALTH INSURANCE¹
Private	1,527	1,396	11,255	10,638	1,035	986	814	802
Medicaid/CHIP	1,089	1,096	7,802	7,807	665	764	861	773
Other²	123^b	255	1,092	1,023	83	107	78	65
No Coverage	86	94	928	851	76	86	110	93
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.42B – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	10.1	10.4	76.4	75.9	6.7	7.2	6.8	6.6
GEOGRAPHIC DIVISION
Northeast	10.5	10.2	75.3	75.9	6.9	7.4	7.3	6.5
New England	10.1	9.4	76.4	78.6	5.6	3.9	7.9	8.1
Middle Atlantic	10.7	10.5	75.0	74.9	7.3	8.6	7.1	5.9
Midwest	9.2	10.3	77.4	75.5	7.5	8.0	5.9	6.2
East North Central	8.2	10.2	77.5	76.0	8.1	7.4	6.2	6.4
West North Central	11.4	10.6	77.2	74.3	6.2	9.1	5.2	6.0
South	9.8	9.7	77.0	76.3	6.3	6.2	6.9	7.7
South Atlantic	9.5	10.0	78.1	74.7	5.6	7.3	6.8	8.0
East South Central	10.7	12.8	73.5	73.3	8.1	4.5	7.7	9.4
West South Central	9.8	7.9	76.8	80.0	6.7	5.4	6.7	6.6
West	11.0	11.6	75.3	75.4	6.6	8.0	7.0^a	5.1
Mountain	13.2	12.7	71.4	75.7	7.2	7.1	8.2^a	4.5
Pacific	9.9	11.0	77.3	75.2	6.3	8.4	6.4	5.3
COUNTY TYPE
Large Metro	9.4	9.9	76.3	76.7	6.9	7.3	7.4	6.0
Small Metro	11.0	10.8	75.9	74.5	7.1	7.2	6.0^a	7.6
Nonmetro	11.3	11.2	78.6	75.4	4.4	6.5	5.7	6.8
Urbanized	11.1	11.1	79.4	74.2	4.9	8.2	4.6	6.5
Less Urbanized	9.8	11.5	80.1	76.7	4.4	5.2	5.8	6.6
Completely Rural	13.5	10.9	75.3	74.8	3.9	6.4	7.2	7.8
POVERTY LEVEL
Less Than 100%	8.8	10.4	76.3	74.1	5.0	6.9	9.9	8.5
100‑199%	9.3	10.5	77.0	75.9	7.1	6.5	6.6	7.1
200% or More	10.9	10.3	76.3	76.6	7.2	7.6	5.7	5.6
HEALTH INSURANCE¹
Private	10.4	10.1	76.9	77.0	7.1	7.1	5.6	5.8
Medicaid/CHIP	10.5	10.5	74.9	74.8	6.4	7.3	8.3	7.4
Other²	8.9^b	17.6	79.4^a	70.6	6.0	7.4	5.6	4.5
No Coverage	7.2	8.4	77.4	75.7	6.3	7.6	9.1	8.3
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.43A – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	MADE ANY SUICIDE PLANS
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	1,186	1,288	22,580	21,878	668	762	1,466	1,430
GEOGRAPHIC DIVISION
Northeast	165	210	3,491	3,420	121	109	299	237
New England	45	48	894	868	32	31	70	60
Middle Atlantic	119	162	2,597	2,553	88	78	228	177
Midwest	243	242	4,778	4,558	155	197	225	284
East North Central	146	144	3,220	3,101	126	120	152	192
West North Central	98	98	1,558	1,458	30^b	77	73	92
South	447	491	9,007	8,664	229	288	613	662
South Atlantic	230	250	4,468	4,261	102	159	318	353
East South Central	74	90	1,333	1,263	36	26	97	134
West South Central	142	150	3,206	3,140	90	103	198	174
West	331	345	5,305	5,236	163	167	329	246
Mountain	130	126	1,713	1,778	90	53	122	89
Pacific	201	220	3,592	3,458	73	114	207	157
COUNTY TYPE
Large Metro	597	682	13,086	12,667	416	392	936^a	727
Small Metro	425	423	7,047	6,943	195	265	413	538
Nonmetro	164	184	2,448	2,269	57^a	104	117	165
Urbanized	42	55	930	838	23	33	41	54
Less Urbanized	71	89	909	970	14^a	39	34	53
Completely Rural	52	39	609	461	19	33	42	58
POVERTY LEVEL
Less Than 100%	236	316	4,657	4,681	135^a	230	470	401
100‑199%	261	315	4,607	4,883	151	145	286	345
200% or More	689	657	13,316	12,314	383	387	710	684
HEALTH INSURANCE¹
Private	665	642	12,959	12,102	350	369	657	709
Medicaid/CHIP	530	604	8,842	8,860	299	342	746	634
Other²	74	114	1,216	1,223	24^a	60	64	53
No Coverage	39	56	1,016	934	46	57	99	77
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.43B – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	MADE ANY SUICIDE PLANS
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	4.6	5.1	87.2	86.3	2.6	3.0	5.7	5.6
GEOGRAPHIC DIVISION
Northeast	4.0	5.3	85.7	86.0	3.0	2.7	7.3	6.0
New England	4.4	4.8	85.8	86.1	3.1	3.1	6.7	6.0
Middle Atlantic	3.9	5.5	85.6	86.0	2.9	2.6	7.5	6.0
Midwest	4.5	4.6	88.4	86.3	2.9	3.7	4.2	5.4
East North Central	4.0	4.0	88.4	87.2	3.5	3.4	4.2	5.4
West North Central	5.6	5.7	88.6^a	84.5	1.7^b	4.5	4.2	5.4
South	4.3	4.9	87.5	85.7	2.2	2.9	6.0	6.6
South Atlantic	4.5	5.0	87.3	84.8	2.0	3.2	6.2	7.0
East South Central	4.8	6.0	86.5	83.4	2.4	1.7	6.3	8.9
West South Central	3.9	4.2	88.2	88.0	2.5	2.9	5.4	4.9
West	5.4	5.8	86.6	87.3	2.7	2.8	5.4	4.1
Mountain	6.3	6.1	83.4	86.9	4.4	2.6	5.9	4.4
Pacific	4.9	5.6	88.2	87.6	1.8	2.9	5.1	4.0
COUNTY TYPE
Large Metro	4.0	4.7	87.0	87.6	2.8	2.7	6.2	5.0
Small Metro	5.3	5.2	87.2^a	85.0	2.4	3.2	5.1	6.6
Nonmetro	5.9	6.8	87.9^a	83.3	2.0^b	3.8	4.2	6.1
Urbanized	4.0	5.6	89.7	85.5	2.3	3.4	4.0	5.5
Less Urbanized	6.9	7.7	88.4	84.2	1.4^a	3.4	3.3	4.6
Completely Rural	7.2	6.7	84.4	78.0	2.6	5.5	5.8	9.8
POVERTY LEVEL
Less Than 100%	4.3	5.6	84.7	83.2	2.5^a	4.1	8.6	7.1
100‑199%	4.9	5.5	86.9	85.8	2.8	2.6	5.4	6.1
200% or More	4.6	4.7	88.2	87.7	2.5	2.8	4.7	4.9
HEALTH INSURANCE¹
Private	4.5	4.6	88.6	87.6	2.4	2.7	4.5	5.1
Medicaid/CHIP	5.1	5.8	84.9	84.9	2.9	3.3	7.2	6.1
Other²	5.3	7.9	88.3	84.4	1.7	4.1	4.6	3.6
No Coverage	3.3	5.0	84.7	83.1	3.8	5.0	8.3	6.9
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.44A – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	ATTEMPTED SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	700	738	23,524	22,896	431	463	1,246	1,261
GEOGRAPHIC DIVISION
Northeast	100	137	3,674	3,574	61	69	239	197
New England	30	18	947	919	11	13	54	57
Middle Atlantic	70	118	2,727	2,655	50	56	185	140
Midwest	150	163	4,941	4,754	93	123	218	243
East North Central	86	91	3,331	3,207	74	86	153	172
West North Central	64	72	1,610	1,547	19	36	66	71
South	296	271	9,358	9,090	137	166	505	578
South Atlantic	157	157	4,651	4,488	71	101	239	278
East South Central	59	40	1,372	1,335	18	16	91	122
West South Central	80	74	3,334	3,266	48	49	175	178
West	154	168	5,551	5,477	140	106	284	243
Mountain	61	70	1,824	1,855	49	23	121	97
Pacific	93	97	3,727	3,622	91	83	162	146
COUNTY TYPE
Large Metro	340	381	13,676	13,175	261	272	760	640
Small Metro	255	247	7,321	7,322	131	142	372	458
Nonmetro	106	110	2,527	2,400	39	49	114	164
Urbanized	31	30	949	891	16	15	40	45
Less Urbanized	48	68	924	1,006	13	26	43	52
Completely Rural	27	12	654	503	10	8	31	67
POVERTY LEVEL
Less Than 100%	185	193	4,817	4,898	108	157	389	380
100‑199%	166	205	4,793	5,096	85	91	261	296
200% or More	350	340	13,915	12,902	238	215	596	585
HEALTH INSURANCE¹
Private	343	332	13,544	12,682	217	211	526	598
Medicaid/CHIP	382	392	9,158	9,251	210	231	667	565
Other²	43	70	1,266	1,292	23	44	45	43
No Coverage	30	33	1,050	959	22	33	97	99
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.44B – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	ATTEMPTED SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
TOTAL	2.7	2.9	90.8	90.3	1.7	1.8	4.8	5.0
GEOGRAPHIC DIVISION
Northeast	2.5	3.4	90.2	89.9	1.5	1.7	5.9	5.0
New England	2.9	1.8	90.9	91.2	1.1	1.2	5.2	5.7
Middle Atlantic	2.3	4.0	89.9	89.4	1.7	1.9	6.1	4.7
Midwest	2.8	3.1	91.5	90.0	1.7	2.3	4.0	4.6
East North Central	2.4	2.6	91.4	90.2	2.0	2.4	4.2	4.8
West North Central	3.6	4.1	91.5	89.6	1.1	2.1	3.7	4.1
South	2.9	2.7	90.9	90.0	1.3	1.6	4.9	5.7
South Atlantic	3.1	3.1	90.9	89.3	1.4	2.0	4.7	5.5
East South Central	3.8	2.7	89.1	88.2	1.2	1.1	5.9	8.1
West South Central	2.2	2.1	91.7	91.6	1.3	1.4	4.8	5.0
West	2.5	2.8	90.6	91.4	2.3	1.8	4.6	4.1
Mountain	3.0	3.4	88.8	90.7	2.4	1.1	5.9	4.7
Pacific	2.3	2.5	91.5	91.7	2.2	2.1	4.0	3.7
COUNTY TYPE
Large Metro	2.3	2.6	91.0	91.1	1.7	1.9	5.1	4.4
Small Metro	3.2	3.0	90.6	89.6	1.6	1.7	4.6	5.6
Nonmetro	3.8	4.0	90.7	88.1	1.4	1.8	4.1	6.0
Urbanized	3.0	3.0	91.6	90.9	1.6	1.5	3.8	4.6
Less Urbanized	4.7	5.9	89.9	87.4	1.2	2.2	4.2	4.5
Completely Rural	3.7	2.1	90.6	85.1	1.4	1.4	4.4^a	11.4
POVERTY LEVEL
Less Than 100%	3.4	3.4	87.6	87.0	2.0	2.8	7.1	6.8
100‑199%	3.1	3.6	90.3	89.6	1.6	1.6	4.9	5.2
200% or More	2.3	2.4	92.2	91.9	1.6	1.5	4.0	4.2
HEALTH INSURANCE¹
Private	2.3	2.4	92.6	91.7	1.5	1.5	3.6	4.3
Medicaid/CHIP	3.7	3.8	87.9	88.6	2.0	2.2	6.4	5.4
Other²	3.1	4.9	91.9	89.2	1.7	3.0	3.2	3.0
No Coverage	2.5	2.9	87.5	85.3	1.9	3.0	8.1	8.8
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.45A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2024 and 2025
Geographic/Socioeconomic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY SUICIDE PLANS, OR ATTEMPTED SUICIDE
	Any of these Suicidality Measures		None of These Suicidality Measures		Unknown
	2024	2025	2024	2025	2024	2025
TOTAL	2,800	2,772	19,593	19,012	3,508	3,574
GEOGRAPHIC DIVISION
Northeast	448	417	3,029	2,974	597	586
New England	118	100	778	782	146	125
Middle Atlantic	331	316	2,251	2,192	451	462
Midwest	546	581	4,151	3,940	705	761
East North Central	338	390	2,800	2,677	506	490
West North Central	208	191	1,352	1,263	199	272
South	1,092	1,043	7,832	7,639	1,372	1,423
South Atlantic	532	546	3,946	3,711	640	767
East South Central	172	205	1,115	1,099	254	210
West South Central	388	292	2,771	2,828	478	447
West	714	732	4,581	4,460	833	803
Mountain	292	274	1,461	1,531	302	241
Pacific	422	458	3,120	2,929	531	561
COUNTY TYPE
Large Metro	1,519	1,514	11,370	10,995	2,146	1,959
Small Metro	952	939	6,052	6,011	1,076	1,218
Nonmetro	329	320	2,171	2,006	286^a	397
Urbanized	121	113	819	708	97^a	159
Less Urbanized	107	138	817	876	104	138
Completely Rural	101	68	535	422	85	100
POVERTY LEVEL
Less Than 100%	517	621	4,137	4,105	843	902
100‑199%	547	638	4,044	4,260	714	791
200% or More	1,736	1,513	11,412	10,647	1,950	1,881
HEALTH INSURANCE¹
Private	1,608	1,494	11,164	10,529	1,859	1,799
Medicaid/CHIP	1,188	1,148	7,694	7,695	1,535	1,596
Other²	132^b	256	1,085	1,007	159	186
No Coverage	97	97	915	837	187	189
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: The “any of these suicidality measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “none of these suicidality measures” category includes respondents with “no” responses to all three measures. The “unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.45B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, or Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2024 and 2025
Geographic/Socioeconomic Characteristic	HAD SERIOUS THOUGHTS OF SUICIDE, MADE ANY SUICIDE PLANS, OR ATTEMPTED SUICIDE
	Any of these Suicidality Measures		None of These Suicidality Measures		Unknown
	2024	2025	2024	2025	2024	2025
TOTAL	10.8	10.9	75.6	75.0	13.5	14.1
GEOGRAPHIC DIVISION
Northeast	11.0	10.5	74.3	74.8	14.7	14.7
New England	11.3	10.0	74.6	77.7	14.1	12.4
Middle Atlantic	10.9	10.7	74.2	73.8	14.9	15.5
Midwest	10.1	11.0	76.8	74.6	13.1	14.4
East North Central	9.3	11.0	76.8	75.3	13.9	13.8
West North Central	11.8	11.1	76.9	73.2	11.3^a	15.8
South	10.6	10.3	76.1	75.6	13.3	14.1
South Atlantic	10.4	10.9	77.1	73.9	12.5	15.3
East South Central	11.2	13.5	72.4	72.6	16.5	13.9
West South Central	10.7	8.2	76.2	79.3	13.1	12.5
West	11.7	12.2	74.7	74.4	13.6	13.4
Mountain	14.2	13.4	71.1	74.8	14.7	11.8
Pacific	10.4	11.6	76.6	74.2	13.0	14.2
COUNTY TYPE
Large Metro	10.1	10.5	75.6	76.0	14.3	13.5
Small Metro	11.8	11.5	74.9	73.6	13.3	14.9
Nonmetro	11.8	11.7	77.9	73.7	10.3^b	14.6
Urbanized	11.7	11.6	79.0^a	72.2	9.3^a	16.2
Less Urbanized	10.4	12.0	79.5	76.0	10.1	12.0
Completely Rural	14.0	11.6	74.2	71.5	11.8	17.0
POVERTY LEVEL
Less Than 100%	9.4	11.0	75.3	72.9	15.3	16.0
100‑199%	10.3	11.2	76.2	74.9	13.5	13.9
200% or More	11.5	10.8	75.6	75.8	12.9	13.4
HEALTH INSURANCE¹
Private	11.0	10.8	76.3	76.2	12.7	13.0
Medicaid/CHIP	11.4	11.0	73.9	73.7	14.7	15.3
Other²	9.6^b	17.6	78.9^b	69.5	11.5	12.8
No Coverage	8.1	8.7	76.3	74.5	15.6	16.8
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Because the 2023 Rural‐Urban Continuum Codes were used to create the county type variables, the 2024 estimates may differ from previously published estimates. NOTE: The “any of these suicidality measures” category includes respondents with one or more “yes” responses to suicidal thoughts, plans, or attempts, regardless of whether they had one or more unknown responses for these measures. The “none of these suicidality measures” category includes respondents with “no” responses to all three measures. The “unknown” category includes respondents who did not respond “yes” to any of the three suicidality questions and who responded “not sure/don’t know” or “don’t want to answer/refuse” to any of the three suicidality questions. Respondents with unknown suicide data other than these categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military‐related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.46A – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode, Receipt of Mental Health Treatment, Perceived Unmet Need for Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Numbers in Thousands, 2024 and 2025
Past Year Mental Health or Substance Use Measure	HAD SERIOUS THOUGHTS OF SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
MAJOR DEPRESSIVE EPISODE¹
Major Depressive Episode	1,559	1,477	1,262	1,179	523	579	497	471
No Major Depressive Episode	964	1,073	18,158	17,737	1,042	1,066	964	998
MENTAL HEALTH TREATMENT AND PERCEIVED UNMET NEED FOR TREATMENT²
Mental Health Treatment	‑‑	1,559	‑‑	4,077	‑‑	661	‑‑	706
No Mental Health Treatment	‑‑	1,066	‑‑	15,158	‑‑	1,165	‑‑	966
Perceived Unmet Need for Treatment³	‑‑	485	‑‑	784	‑‑	321	‑‑	190
Did Not Seek Treatment and Did Not Think Should Get Treatment³	‑‑	569	‑‑	14,262	‑‑	748	‑‑	752
SUBSTANCE USE DISORDER⁴
Substance Use Disorder	712^a	523	931	940	189	198	188	203
Alcohol Use Disorder	314^a	208	304	373	80	68	77	55
Drug Use Disorder	616^a	453	776	702	162	164	149	184
No Substance Use Disorder	1,901	2,102	18,862	18,296	1,551	1,627	1,566	1,470
SUBSTANCE USE TREATMENT⁵
Substance Use Treatment	‑‑	127	‑‑	249	‑‑	21	‑‑	63
No Substance Use Treatment	‑‑	2,498	‑‑	18,986	‑‑	1,804	‑‑	1,610
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ³ Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ⁴ Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ⁵ Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.46B – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode, Receipt of Mental Health Treatment, Perceived Unmet Need for Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Percentages, 2024 and 2025
Past Year Mental Health or Substance Use Measure	HAD SERIOUS THOUGHTS OF SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
MAJOR DEPRESSIVE EPISODE¹
Major Depressive Episode	40.6	39.9	32.9	31.8	13.6	15.6	12.9	12.7
No Major Depressive Episode	4.6	5.1	85.9	85.0	4.9	5.1	4.6	4.8
MENTAL HEALTH TREATMENT AND PERCEIVED UNMET NEED FOR TREATMENT²
Mental Health Treatment	‑‑	22.3	‑‑	58.2	‑‑	9.4	‑‑	10.1
No Mental Health Treatment	‑‑	5.8	‑‑	82.6	‑‑	6.3	‑‑	5.3
Perceived Unmet Need for Treatment³	‑‑	27.2	‑‑	44.1	‑‑	18.0	‑‑	10.7
Did Not Seek Treatment and Did Not Think Should Get Treatment³	‑‑	3.5	‑‑	87.3	‑‑	4.6	‑‑	4.6
SUBSTANCE USE DISORDER⁴
Substance Use Disorder	35.2^a	28.1	46.1	50.4	9.4	10.6	9.3	10.9
Alcohol Use Disorder	40.5^a	29.5	39.2^b	53.0	10.4	9.6	9.9	7.9
Drug Use Disorder	36.2	30.1	45.6	46.7	9.5	10.9	8.7	12.2
No Substance Use Disorder	8.0	8.9	79.0	77.9	6.5	6.9	6.6	6.3
SUBSTANCE USE TREATMENT⁵
Substance Use Treatment	‑‑	27.7	‑‑	54.1	‑‑	4.6	‑‑	13.6
No Substance Use Treatment	‑‑	10.0	‑‑	76.3	‑‑	7.2	‑‑	6.5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ³ Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ⁴ Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ⁵ Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.47A – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode, Receipt of Mental Health Treatment, Perceived Unmet Need for Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Numbers in Thousands, 2024 and 2025
Past Year Mental Health or Substance Use Measure	MADE ANY SUICIDE PLANS
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
MAJOR DEPRESSIVE EPISODE¹
Major Depressive Episode	761	740	2,388	2,306	245	262	445	397
No Major Depressive Episode	375^a	504	19,684	19,154	286	377	782	838
MENTAL HEALTH TREATMENT AND PERCEIVED UNMET NEED FOR TREATMENT²
Mental Health Treatment	‑‑	820	‑‑	5,227	‑‑	334	‑‑	623
No Mental Health Treatment	‑‑	468	‑‑	16,651	‑‑	428	‑‑	807
Perceived Unmet Need for Treatment³	‑‑	207	‑‑	1,289	‑‑	106	‑‑	178
Did Not Seek Treatment and Did Not Think Should Get Treatment³	‑‑	255	‑‑	15,206	‑‑	266	‑‑	605
SUBSTANCE USE DISORDER⁴
Substance Use Disorder	413	314	1,339	1,259	99	97	170	193
Alcohol Use Disorder	190	143	462	485	48	28	74	48
Drug Use Disorder	376	276	1,128	973	71	89	127	166
No Substance Use Disorder	773^a	974	21,242	20,619	569	665	1,297	1,237
SUBSTANCE USE TREATMENT⁵
Substance Use Treatment	‑‑	78	‑‑	286	‑‑	26	‑‑	69
No Substance Use Treatment	‑‑	1,210	‑‑	21,592	‑‑	736	‑‑	1,360
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ³ Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ⁴ Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ⁵ Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.47B – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode, Receipt of Mental Health Treatment, Perceived Unmet Need for Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Percentages, 2024 and 2025
Past Year Mental Health or Substance Use Measure	MADE ANY SUICIDE PLANS
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
MAJOR DEPRESSIVE EPISODE¹
Major Depressive Episode	19.8	20.0	62.2	62.2	6.4	7.1	11.6	10.7
No Major Depressive Episode	1.8^a	2.4	93.2^a	91.8	1.4	1.8	3.7	4.0
MENTAL HEALTH TREATMENT AND PERCEIVED UNMET NEED FOR TREATMENT²
Mental Health Treatment	‑‑	11.7	‑‑	74.6	‑‑	4.8	‑‑	8.9
No Mental Health Treatment	‑‑	2.6	‑‑	90.7	‑‑	2.3	‑‑	4.4
Perceived Unmet Need for Treatment³	‑‑	11.6	‑‑	72.4	‑‑	6.0	‑‑	10.0
Did Not Seek Treatment and Did Not Think Should Get Treatment³	‑‑	1.6	‑‑	93.1	‑‑	1.6	‑‑	3.7
SUBSTANCE USE DISORDER⁴
Substance Use Disorder	20.5	16.9	66.2	67.6	4.9	5.2	8.4	10.3
Alcohol Use Disorder	24.6	20.3	59.7	68.9	6.3	4.0	9.5	6.8
Drug Use Disorder	22.1	18.3	66.3	64.7	4.2	5.9	7.5	11.0
No Substance Use Disorder	3.2^a	4.1	89.0	87.8	2.4	2.8	5.4	5.3
SUBSTANCE USE TREATMENT⁵
Substance Use Treatment	‑‑	17.0	‑‑	62.2	‑‑	5.7	‑‑	15.1
No Substance Use Treatment	‑‑	4.9	‑‑	86.7	‑‑	3.0	‑‑	5.5
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ³ Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ⁴ Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ⁵ Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.48A – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode, Receipt of Mental Health Treatment, Perceived Unmet Need for Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Numbers in Thousands, 2024 and 2025
Past Year Mental Health or Substance Use Measure	ATTEMPTED SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
MAJOR DEPRESSIVE EPISODE¹
Major Depressive Episode	394	395	2,922	2,775	145	176	378	359
No Major Depressive Episode	279	316	20,003	19,668	182	172	663	717
MENTAL HEALTH TREATMENT AND PERCEIVED UNMET NEED FOR TREATMENT²
Mental Health Treatment	‑‑	498	‑‑	5,724	‑‑	237	‑‑	545
No Mental Health Treatment	‑‑	240	‑‑	17,172	‑‑	226	‑‑	716
Perceived Unmet Need for Treatment³	‑‑	78	‑‑	1,473	‑‑	71	‑‑	156
Did Not Seek Treatment and Did Not Think Should Get Treatment³	‑‑	159	‑‑	15,536	‑‑	101	‑‑	536
SUBSTANCE USE DISORDER⁴
Substance Use Disorder	280	212	1,482	1,438	75	58	184	155
Alcohol Use Disorder	139	89	526	551	30	13	80	50
Drug Use Disorder	240	190	1,257	1,134	56	51	148	128
No Substance Use Disorder	420	526	22,042	21,458	356	405	1,062	1,106
SUBSTANCE USE TREATMENT⁵
Substance Use Treatment	‑‑	72	‑‑	319	‑‑	20	‑‑	49
No Substance Use Treatment	‑‑	666	‑‑	22,577	‑‑	443	‑‑	1,212
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ³ Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ⁴ Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ⁵ Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.48B – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode, Receipt of Mental Health Treatment, Perceived Unmet Need for Mental Health Treatment, Substance Use Disorder, and Substance Use Treatment, Percentages, 2024 and 2025
Past Year Mental Health or Substance Use Measure	ATTEMPTED SUICIDE
	Yes		No		Not Sure/Don’t Know		Don’t Want to Answer/Refuse
	2024	2025	2024	2025	2024	2025	2024	2025
MAJOR DEPRESSIVE EPISODE¹
Major Depressive Episode	10.3	10.7	76.1	74.9	3.8	4.8	9.8	9.7
No Major Depressive Episode	1.3	1.5	94.7	94.2	0.9	0.8	3.1	3.4
MENTAL HEALTH TREATMENT AND PERCEIVED UNMET NEED FOR TREATMENT²
Mental Health Treatment	‑‑	7.1	‑‑	81.7	‑‑	3.4	‑‑	7.8
No Mental Health Treatment	‑‑	1.3	‑‑	93.6	‑‑	1.2	‑‑	3.9
Perceived Unmet Need for Treatment³	‑‑	4.4	‑‑	82.8	‑‑	4.0	‑‑	8.8
Did Not Seek Treatment and Did Not Think Should Get Treatment³	‑‑	1.0	‑‑	95.1	‑‑	0.6	‑‑	3.3
SUBSTANCE USE DISORDER⁴
Substance Use Disorder	13.8	11.4	73.3	77.2	3.7	3.1	9.1	8.3
Alcohol Use Disorder	17.9	12.7	67.9^a	78.3	3.8	1.9	10.3	7.1
Drug Use Disorder	14.1	12.6	73.9	75.5	3.3	3.4	8.7	8.5
No Substance Use Disorder	1.8	2.2	92.3	91.3	1.5	1.7	4.4	4.7
SUBSTANCE USE TREATMENT⁵
Substance Use Treatment	‑‑	15.6	‑‑	69.5	‑‑	4.3	‑‑	10.6
No Substance Use Treatment	‑‑	2.7	‑‑	90.7	‑‑	1.8	‑‑	4.9
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inpatient and outpatient substance use treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Changes were made to the inpatient and outpatient mental health treatment questions during 2024, after the start of data collection. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Major depressive episode aligns with DSM‑5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. ² Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling, outpatient treatment/counseling, use of prescription medication, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. ³ Respondents were classified as having a perceived unmet need for mental health treatment (MH Tx) if they did not receive MH Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for MH Tx were excluded. ⁴ Substance use disorder is based on DSM‑5 criteria. See Chapter 3 of the 2025 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ⁵ Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling, outpatient treatment/counseling, medications for alcohol or opioid use disorder, telehealth treatment, or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.49A – Attempted Suicide in Past Year: Among People Aged 12 to 17; Received Medical Attention for Suicide Attempt in Past Year and Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year: Among People Aged 12 to 17 Who Attempted Suicide in Past Year; by Age Group and Sex, Numbers in Thousands, 2024 and 2025
Suicidal Behavior/Treatment for Suicide Attempt	Aged 12‑17 (2024)	Aged 12‑17 (2025)	Aged 12‑13 (2024)	Aged 12‑13 (2025)	Aged 14‑15 (2024)	Aged 14‑15 (2025)	Aged 16‑17 (2024)	Aged 16‑17 (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
ATTEMPTED SUICIDE
Yes	700	738	210	225	219	279	271	233	220	178	480	560
No	23,524	22,896	7,241	6,959	8,085	7,814	8,198	8,123	12,327	12,063	11,197	10,833
Not Sure/Don’t Know	431	463	136	166	174	126	121	171	198	171	233	292
Don’t Want to Answer/Refuse	1,246	1,261	493	472	369	455	384	334	495	543	751	718
RECEIVED MEDICAL ATTENTION FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE
Yes	284	269	*	*	*	*	96	*	*	*	172	190
No	387	431	*	*	*	*	169	*	*	*	285	342
Not Sure/Don’t Know	8	22	*	*	*	*	1	*	*	*	6	*
Don’t Want to Answer/Refuse	21	16	*	*	6	7	4	*	4	*	17	12
STAYED OVERNIGHT OR LONGER IN A HOSPITAL FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE
Yes	177	193	*	28	39	*	80	*	*	*	100	145
No	486	505	*	184	167	*	185	*	*	*	349	384
Not Sure/Don’t Know	3	1	*	*	*	*	*	*	*	*	3	1
Don’t Want to Answer/Refuse	*	1	*	<1	<1	1	*	*	*	*	*	1
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

260522

Table 7.49B – Attempted Suicide in Past Year: Among People Aged 12 to 17; Received Medical Attention for Suicide Attempt in Past Year and Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year: Among People Aged 12 to 17 Who Attempted Suicide in Past Year; by Age Group and Sex, Percentages, 2024 and 2025
Suicidal Behavior/Treatment for Suicide Attempt	Aged 12‑17 (2024)	Aged 12‑17 (2025)	Aged 12‑13 (2024)	Aged 12‑13 (2025)	Aged 14‑15 (2024)	Aged 14‑15 (2025)	Aged 16‑17 (2024)	Aged 16‑17 (2025)	Male (2024)	Male (2025)	Female (2024)	Female (2025)
ATTEMPTED SUICIDE
Yes	2.7	2.9	2.6	2.9	2.5	3.2	3.0	2.6	1.7	1.4	3.8	4.5
No	90.8	90.3	89.6	89.0	91.4	90.1	91.4	91.7	93.1	93.1	88.4	87.3
Not Sure/Don’t Know	1.7	1.8	1.7	2.1	2.0	1.5	1.3	1.9	1.5	1.3	1.8	2.4
Don’t Want to Answer/Refuse	4.8	5.0	6.1	6.0	4.2	5.2	4.3	3.8	3.7	4.2	5.9	5.8
RECEIVED MEDICAL ATTENTION FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE
Yes	40.6	36.4	*	*	*	*	35.6	*	*	*	35.9	33.9
No	55.3	58.4	*	*	*	*	62.4	*	*	*	59.4	61.1
Not Sure/Don’t Know	1.1	3.0	*	*	*	*	0.5	*	*	*	1.2	*
Don’t Want to Answer/Refuse	3.0	2.1	*	*	2.6	2.4	1.5	*	2.0	*	3.5	2.1
STAYED OVERNIGHT OR LONGER IN A HOSPITAL FOR SUICIDE ATTEMPT AMONG PEOPLE WHO ATTEMPTED SUICIDE
Yes	26.4	27.5	*	13.3	18.6	*	30.1	*	*	*	21.8	27.2
No	72.4	72.1	*	86.5	79.8	*	69.9	*	*	*	76.4	72.2
Not Sure/Don’t Know	0.4	0.2	*	*	*	*	*	*	*	*	0.7	0.3
Don’t Want to Answer/Refuse	*	0.2	*	0.2	0.2	0.3	*	*	*	*	*	0.2
* = low precision; ‑‑ = not available or not shown due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,” “Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ^a,b The difference between this estimate and the 2025 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2024 and 2025.

▲ TOP TOC